US12036019B2 - Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis - Google Patents
Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis Download PDFInfo
- Publication number
- US12036019B2 US12036019B2 US17/227,131 US202117227131A US12036019B2 US 12036019 B2 US12036019 B2 US 12036019B2 US 202117227131 A US202117227131 A US 202117227131A US 12036019 B2 US12036019 B2 US 12036019B2
- Authority
- US
- United States
- Prior art keywords
- light
- analog
- log
- biological sample
- adc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 67
- 239000008280 blood Substances 0.000 title claims abstract description 67
- 239000008103 glucose Substances 0.000 title claims abstract description 47
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title claims abstract description 46
- 238000000034 method Methods 0.000 title abstract description 22
- 230000003595 spectral effect Effects 0.000 title abstract description 8
- 230000003287 optical effect Effects 0.000 title description 27
- 238000001514 detection method Methods 0.000 title description 14
- 238000007405 data analysis Methods 0.000 title description 6
- 239000012472 biological sample Substances 0.000 claims abstract description 23
- 239000000523 sample Substances 0.000 claims abstract description 22
- 230000001419 dependent effect Effects 0.000 claims abstract description 12
- 230000036962 time dependent Effects 0.000 claims abstract description 10
- 230000000694 effects Effects 0.000 claims abstract description 9
- 230000004044 response Effects 0.000 claims abstract description 9
- 230000008859 change Effects 0.000 claims description 19
- 238000002835 absorbance Methods 0.000 claims description 12
- 238000010606 normalization Methods 0.000 claims description 12
- 230000031700 light absorption Effects 0.000 claims description 9
- 238000005259 measurement Methods 0.000 description 27
- 206010012601 diabetes mellitus Diseases 0.000 description 15
- 125000004122 cyclic group Chemical group 0.000 description 11
- 230000002238 attenuated effect Effects 0.000 description 7
- 230000000541 pulsatile effect Effects 0.000 description 6
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000010238 partial least squares regression Methods 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 210000003722 extracellular fluid Anatomy 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 206010034972 Photosensitivity reaction Diseases 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000000624 ear auricle Anatomy 0.000 description 2
- 230000005057 finger movement Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 208000017169 kidney disease Diseases 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000036211 photosensitivity Effects 0.000 description 2
- 238000000611 regression analysis Methods 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012935 Averaging Methods 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000010837 Diabetic eye disease Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000011272 standard treatment Methods 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6813—Specially adapted to be attached to a specific body part
- A61B5/6825—Hand
- A61B5/6826—Finger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/683—Means for maintaining contact with the body
- A61B5/6838—Clamps or clips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7225—Details of analog processing, e.g. isolation amplifier, gain or sensitivity adjustment, filtering, baseline or drift compensation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
- G16Z99/00—Subject matter not provided for in other main groups of this subclass
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0233—Special features of optical sensors or probes classified in A61B5/00
- A61B2562/0238—Optical sensor arrangements for performing transmission measurements on body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2576/00—Medical imaging apparatus involving image processing or analysis
Abstract
Systems and methods are disclosed for non-invasively measuring blood glucose levels in a biological sample based on spectral data. This includes a light source to strike a target area of a sample, a light detector positioned to receive light from the light source and to generate an output signal, having a time dependent current, which is indicative of the power of light detected, a processor to receive the output signal from the light detector based on the received output signal, calculate the attenuance attributable to blood in a sample present in the target area with a ratio factor, eliminate effect of uncertainty caused by temperature dependent detector response of the light detector, and then determine a blood glucose level associated with a sample present in the target area based on the calculated attenuance with the processor.
Description
This application is a continuation patent application of co-pending U.S. patent application Ser. No. 15/878,268, filed Jan. 23, 2018, and entitled METHOD AND SYSTEM FOR NON-INVASIVE OPTICAL BLOOD GLUCOSE DETECTION UTILIZING SPECTRAL DATA ANALYSIS, which is a continuation patent application of U.S. patent application Ser. No. 15/464,253, filed Mar. 20, 2017, and entitled METHOD AND SYSTEM FOR NON-INVASIVE OPTICAL BLOOD GLUCOSE DETECTION UTILIZING SPECTRAL DATA ANALYSIS, which is a continuation patent application of U.S. patent application Ser. No. 13/610,423, filed Sep. 11, 2012, issued as U.S. Pat. No. 9,629,576 and entitled METHOD AND SYSTEM FOR NON-INVASIVE OPTICAL BLOOD GLUCOSE DETECTION UTILIZING SPECTRAL DATA ANALYSIS, which is a divisional of prior U.S. Patent Application Number 12/425,535, filed Apr. 17, 2009, issued as U.S. Pat. No. 8,340,738, which are all hereby incorporated herein by reference in their entirety, and also claims priority to U.S. Provisional Patent Application Ser. No. 61/055,303, filed on May 22, 2008, the disclosure of which is incorporated herein by reference, and also claims priority to U.S. Provisional Patent Application Serial Number 61/089,152, filed on Aug. 15, 2008, the disclosure of which is incorporated herein by reference.
Diabetes is a chronic disease that, when not controlled, over time leads to serious damage to many of the body's systems, including the nerves, blood vessels, eyes, kidneys and heart. The National institute of Diabetes and Digestive and Kidney Diseases (NIDDK) estimates that 23.6 million people, or 7.8 percent of the population in the United States, had diabetes in 2007. Globally, the World Health Organization (WHO) estimates that more than 180 million people have diabetes, a number they expect to increase to 366 million by 2030, with 30.3 million in the United States. According to the WHO, an estimated 1.1 million people died from diabetes in 2005. They project that diabetes deaths will increase by more than 50% between 2006 and 2015 overall and by more than 80% in upper-middle income countries.
The economic burden from diabetes for individuals and society as a whole is substantial. According to the American Diabetes Association, the total annual economic cost of diabetes was estimated to be $174 billion in the United States in 2007. This is an increase of $42 billion since 2002. This 32% increase means the dollar amount has risen over 58 billion more each year.
A vital element of diabetes management is the self-monitoring of blood glucose (SMBG) concentration by diabetics in the home environment. By testing blood glucose levels often, diabetics can better manage medication, diet, and exercise to maintain control and prevent the long-term negative health outcomes. In fact, the Diabetes Control and Complications Trial (DCCT), which followed 1,441 diabetics for several years, showed that those following an intensive-control program with multiple blood sugar tests each day, as compared with the standard-treatment group, had only one-fourth as many people develop diabetic eye disease, half as many develop kidney disease, one-third as many develop nerve disease, and far fewer people who already had early forms of these three complications got worse.
However, current monitoring techniques discourage regular use due to the inconvenient and painful nature of drawing blood through the skin prior to analysis, which causes many diabetics to not be as diligent as they should be for good blood glucose control. As a result, non-invasive measurement of glucose concentration is a desirable and beneficial development for the management of diabetes. A non-invasive monitor will make testing multiple times each day pain-free and more palatable for children with diabetes. According to a study published in 2005 (J. Wagner, C. Malchoff, and G. Abbott, Diabetes Technology & Therapeutics, 7(4) 2005, 612-619), people with diabetes would perform SMBG more frequently and have improved quality of life with a non-invasive blood glucose monitoring device.
There exist a number of non-invasive approaches for blood glucose determination. One technique of non-invasive blood chemical detection involves collecting and analyzing light spectra data.
Extracting information about blood characteristics, such as glucose concentration from spectral or other data obtained from spectroscopy, is a complex problem due to the presence of components (e.g., skin, fat, muscle, bone, interstitial fluid) other than blood in the area that is being sensed. Such other components can influence these signals in such a way as to alter the reading. In particular, the resulting signal may be much larger in magnitude than the portion of the signal that corresponds to blood, and therefore limits the ability to accurately extract blood characteristics information.
The present invention is directed to overcoming one or more of the problems set forth above.
In an aspect of the present invention, a method for detecting glucose in a biological sample is disclosed. The method includes utilizing at least one light source configured to strike a target area of a sample, utilizing at least one light detector positioned to receive light from the at least one light source and to generate an output signal, having a time dependent current, which is indicative of the power of light detected, receiving the output signal from the at least one light detector with a processor and based on the received output signal, calculating the attenuance attributable to blood in a sample present in the target area with a ratio factor with the processor, eliminating effect of uncertainty caused by temperature dependent detector response of the at least one light detector with the processor, and determining a blood glucose level associated with a sample present in the target area with the processor based on the calculated attenuance with the processor.
In yet another aspect of the present invention, a system for detecting glucose in a biological sample is disclosed. This system includes at least one light source configured to strike a target area of a sample, at least one light detector positioned to receive light from the at least one light source and to generate an output signal, having a time dependent current, which is indicative of the power of light detected, a processor configured to receive the output signal from the at least one light detector based on the received output signal, calculate the attenuance attributable to blood in a sample present in the target area with a ratio factor, eliminate effect of uncertainty caused by temperature dependent detector response of the at least one light detector, and then determine a blood glucose level associated with a sample present in the target area based on the calculated attenuance with the processor.
These are merely some of the innumerable aspects of the present invention and should not be deemed an all-inclusive listing of the innumerable aspects associated with the present invention.
For a better understanding of the present invention, reference may be made to accompanying drawings, in which:
In the following detailed description, numerous exemplary specific details are set firth in order to provide a thorough understanding of the invention. However, it will be understood by those skilled in the art that the present invention may be practiced without these specific details, or with various modifications of the details. In other instances, well known methods, procedures, and components have not been described in detail so as not to obscure the present invention.
Optical spectroscopy can be used to determine the amount of light absorbed and scattered, i.e., attenuated, by a biological sample such as a human finger. By measuring the amount of light absorbed by the sample, it is possible to determine glucose, cholesterol, and hemoglobin levels of a subject non-invasively. Fingertip measurements are usually preferred because of the large concentration of capillaries in the fingertip and because of the conversion of arterial blood into venous blood that occurs in the fingertip. However, the techniques of the present invention are not limited to use with a fingertip. For example, the biological sample could be a human earlobe.
When light is transmitted through a biological sample, such as a human finger, the light is attenuated by various components of the finger including skin, muscle, bone, fat, interstitial fluid and blood. It has been observed, however, that light attenuation by a human finger exhibits a small cyclic pattern that corresponds to a heartbeat. It is believed that this cyclic pattern will be present in measurements of many other human body parts, the earlobe being one of many examples.
Assuming that the peak of the cyclic photocurrent generated by the light-sensing device is Ip, the adjacent valley of the cyclic photocurrent is Iv, and the photocurrent generated by the light-sensing device without a human finger is I0, the transmittances corresponding to the peak and valley photocurrents can be defined as:
and
The corresponding peak and valley absorbance are:
A v=−log(T v) (3)
and
A p=−log(T p) (4)
A v=−log(T v) (3)
and
A p=−log(T p) (4)
The difference between Av and Ap represents the light absorption and scattering by the blood in the finger, excluding non-blood constituents:
As can be seen in the algorithm shown in Equation (5), ΔA does not depend on I0. Thus, calculating ΔA does not require a determination of the current generated by the light-sensing device without a sample. Monitoring the photocurrent corresponding to light power transmitted through a sample is sufficient to calculate ΔA.
A first aperture 212 ensures that the light beams 204, 206, 208, 210 strike a target area of the finger. A second aperture 214 ensures that the portion of the light beams that are transmitted through the finger strike a lens 216. Light beams 204, 206, 208, 210 are attenuated by the finger and components of the optical measurement system 200, and, thus, attenuated light beams 218, 220, 222, 224 are emitted from the finger. The attenuated light beams 218, 220, 222, 224 strike the lens 216, and the lens 216 collects the attenuated light beams 218, 220, 222, 224 so that they impinge more efficiently on a detector block 226.
The detector block 226 is positioned directly under the lens 216 and comprises a plurality of light-sensing devices (LSD) 228, 230, 232, 234 such as an array of photodiodes. According to one aspect of the optical measurement system 200, each of the light-sensing devices 228, 230, 232, 234 detects a specific wavelength of light as defined by corresponding interference filters (IF) 236, 238, 240, 242, respectively. The interference filter transmits one or more spectral bands or lines of light, and blocks others.
Each of the light-sensing devices 228, 230, 232, 234 generates a corresponding photocurrent signal that is proportional to the power of the light received by the particular light sensing device. The photocurrent signal generated by the photodiode can be converted to another form of signal, such as an analog voltage signal or a digital signal. A processor 243 is coupled to the detector block 226 and is configured to calculate the change of photocurrent signals 244, 246, 248, 250.
According to one aspect, the processor 243 executes an algorithm such as shown in the Equation (5) to calculate the change in the light absorption (ΔA) solely caused by the blood in the finger. Thereafter, this quantitative calculation of light absorption of the blood can be used to determine a characteristic of the blood. For example, by comparing the calculated light absorption value to predetermined values corresponding to different glucose levels stored in a memory (not shown), a blood-glucose level of the subject can be determined.
A difficulty associated with the finger based pulsatile detection methodology is low signal-to-noise (S/N) ratio, because the amplitude of cyclic pattern (i.e., the difference between peak and valley) is typically 1%-2% of the total photocurrent generated by the light power transmitted through the finger. To obtain a S/N ratio of 100:1 in the determination of ΔA, the baseline noise of the device being used to measure the light absorption by the finger should not be larger than 3.0×10−5 in absorbance (peak to peak), within a 10 Hz bandwidth.
However, a 3.0×10−5 absorbance (peak to peak) baseline noise level within a 10 Hz bandwidth is difficult to obtain with the low light power levels that are used by some battery-powered hand held non-invasive blood chemical measurement devices. One solution involves data averaging. To increase the S/N ratio, the averaged value of ΔA, as defined by the Equation below, is used in further calculation to extract blood glucose concentration:
In Equation (6), M is the number of heartbeats during the time interval of the pulsatile measurement. However, this approach requires long data acquisition time, due to the fact that the rate of heartbeat is in the order of one per second. For example, 25 seconds would be needed fir increasing the S/N ratio by a factor of five, and 100 seconds would be needed for increasing the S/N ratio by a factor often. In comparison, current commercial blood drawing glucose meters can determine blood glucose level within 5 seconds. Furthermore, long detection time will significantly increase measurement errors due to finger movement, light power drift, device temperature change, etc. Thus, there is a need for new techniques to measure blood glucose levels quickly and accurately.
Improving S/N Ratio by Standard Deviation
The time dependent detector photocurrent output, ID(t), shown in FIG. 1 can be expressed as the sum of a small time dependent cyclic photocurrent ΔI(t), corresponding to the heartbeat, a noise current n(t), and a constant baseline photocurrent IB:
I D(t)=I B +ΔI(t)+n(t) (7)
I D(t)=I B +ΔI(t)+n(t) (7)
The above Equation can be re-arranged as:
Applying common logarithm to both side of the Equation (8), one obtains:
σ[A(t)]=kΔA (10)
in which σ[A(t)] is the Standard Deviation of A(I), and k is a proportional constant.
Considering the fact that IB is a constant and σ2(log IB)=0, one obtains:
σ[A(t)]=σ[log I D(t)] (12)
σ[A(t)]=σ[log I D(t)] (12)
Therefore, the peak-to-valley height of the A(t) plot during the time interval of one heartbeat can be obtained directly from the standard deviation of the logarithm of ID(t):
A major advantage of Equation (13) is that high S/N ratio can be achieved within short data acquisition time (approximately one second), as explained below.
In a finger based pulsatile measurement depicted by FIG. 2 , the value of the sum, ΔI(t)+n(t) is typically less than 2% of the large constant baseline photocurrent IB. Therefore, Equation (9) can be approximated as:
Similarly, the standard deviation of A(t) can be approximated as:
Equation (15) demonstrates great noise reduction power of Equation (13). For example, for a relatively high baseline noise with the ratio
the contribution to σ[A(t)] from the baseline noise n(t) is estimated to be less than 0.005 (or 0.5%), corresponding to an increase in S/N ratio by a factor of 20 without increasing detection time. As such, dramatic noise reduction can be obtained without increasing the data acquisition time, and a finger based pulsatile measurement can be completed within the time interval of one heartbeat (which is approximately one second), and the requirement for the S/N ratio of 100 to 1 in determination of ΔA can be satisfied using an optical system with a baseline noise of about 6.0×10−4 absorbance (peak to peak) within a 10 bandwidth. It should be pointed out that when the baseline noise of an optical system is dominated by shot noise due to low light illumination power, a noise reduction by a factor of 20 equals an increasing in light illumination power by a factor of 20 2=400.
This ability of obtaining higher S/N ratio within the very short data acquisition time, e.g., less than one second, will significantly reduce detection error caused by factors such as finger movement, temperature change, and light power drift during the measurement, and therefore dramatically improve the accuracy and reproducibility of the pulsatile detection methodology.
Furthermore, the value of k does not change with wavelength, because transmitted lights at all wavelengths have identical pulse shape due to the heartbeat. As a result, the constant k will be cancelled in data normalization discussed in next section, and σ[log ID(t)] will be used in further regression analysis to establish correlation between the optical measurement and blood glucose level. This will greatly simplify the data analysis process since σ[log ID(t)] involves only two standard math functions available in most popular spreadsheet programs such as Microsoft EXCEL®, EXCEL® is a federally registered trademark of Microsoft Corporation, having a place of business at One Microsoft Way, Redmond, Washington 98052-6399.
Normalization
At each wavelength λi, the absorption ΔA(λi) is linked to the increase of amount of blood (ΔB) in the optical sensing area of the fingertip due to the heartbeat by the following Equation:
ΔA(λi)=ε(C,λ i ,T)ΔB (16)
in which ε(C, λi, T) is the absorption/scattering coefficient of blood at wavelength finger temperature T, and blood glucose concentration C. It is well understood that the variable ΔB differs from person to person, and may even change from day to day for the same person.
ΔA(λi)=ε(C,λ i ,T)ΔB (16)
in which ε(C, λi, T) is the absorption/scattering coefficient of blood at wavelength finger temperature T, and blood glucose concentration C. It is well understood that the variable ΔB differs from person to person, and may even change from day to day for the same person.
The uncertainty from the variable ΔB can be cancelled by introducing the normalization factor Qi(C,T) at each wavelength λi, as defined by the Equation below:
in which N is total number of wavelength employed. Preferably, N typically ranges from twenty to thirty.
Based on Equations (13) and (17), Qi(C,T) is linked to the detector photocurrent at each wavelength λi, ID(λi,T) by the following Equation:
As shown by Equation (18), the constant k is cancelled and σ[log ID(t)] will be used in further regression analysis to establish correlation between the optical measurement and blood glucose level. This is possible because data are taken simultaneously from all detection channels.
A correlation between optical measurement and blood glucose concentration can be established according to the following Equation:
in which Coptical is the blood glucose concentration predicted by the optical measurement, Qi(C,T) is defined by Equations (17) and (18), and ai(T) is the temperature dependent regression coefficient corresponding to wavelength λi. The values of ai(T) can be extracted using proper statistics methods such as Partial Least Squares (PLS) regression.
Equation (19) represents ideal cases when large number of calibrations can be made at different finger temperatures. In reality, frequently only a limited number of calibrations can be made (e.g., 15 to 20), and each may be taken at a different finger temperature. Under this condition, the finger temperature can be treated as an independent variable, and the above Equation can be approximated as:
in which bi is the temperature independent regression coefficient corresponding to wavelength λi, and η is the regression coefficient for the finger temperature. The values of bi and that of η can be extracted using proper statistics methods such as Partial Least Squares (PLS) regression.
Ratio Methodology
Alternatively, the uncertainty from the variable ΔB can be cancelled by introducing a ratio factor Yij at wavelength
in which j can be any number from 1 to N, assuming that the device collects signal at all N wavelengths.
Similar to the normalization algorithm discussed before, a correlation between optical measurement and blood glucose level can be established according to the following Equation:
in which Coptional is the blood glucose concentration predicted by the optical measurement, Yij(C,T) is defined by Equation (21), and fi(T) is the temperature dependent regression coefficient corresponding to wavelength λi. The value of fi(T) can be obtained using statistics methods such as Partial Least Squares (PLS) regression.
Equation (22) represents ideal cases when large number of calibration can be made at different finger temperatures. In reality, frequently only limited number of calibration can be made (e.g., 15 to 20), and each may be taken at a different finger temperature. Under this condition, the finger temperature can be treated as an independent variable, and the above Equation can be approximated as:
in which h1 is the temperature independent regression coefficient corresponding to wavelength λi, and β is the regression coefficient for the finger temperature. The values of h1 and that of β can be extracted using proper statistics methods such as Partial Least Squares (PLS) regression.
Elimination of the Effect of Temperature Dependent Device Response
It is well understood that the detector sensitivity of a silicon photodiode detector is a function of wavelength and temperature. For the device configuration shown in FIG. 2 , which is generally indicated by numeral 200, the light power received by ith silicon diode detector, corresponding to wavelength λi, is converted into a photocurrent according to the following Equation:
I D(λi ,t)=P(λi ,t)S 0(λi)[1+γ(λi)(T Di ,t)−25° C.)] (24)
I D(λi ,t)=P(λi ,t)S 0(λi)[1+γ(λi)(T Di ,t)−25° C.)] (24)
In the above Equation (24), P(λi, t) is the light power received by the detector, S0(λi) is the photosensitivity of the detector at wavelength λi and 25° C., γ(λi) is the temperature coefficient of the photosensitivity at wavelength λi, and TDi(t) is the temperature of ith photodiode detector. The temperature coefficient γ(λi) varies with the wavelength. For example, for Hamamatsu S1337 series photodiode detectors, γ(λi) ranges from near zero at 900 nm to over 1.0%/° C. at 1100 nm. This imposes a potential problem for the device configuration show in FIG. 2 , because it is very difficult to keep temperature of each individual diode detector constant in a handheld device used by a person with diabetes under a normal household/office environment. This uncertainty due to the detector temperature T (I) can be eliminated using the algorithm shown by Equations (12) and (13). Applying common logarithm on both sides of the Equation (24), one obtains:
log I D(λi ,t)=log P(λi ,t)+log S 0(λi)+log[1+γ(λi)(T Di(t)−25° C.)] (25)
log I D(λi ,t)=log P(λi ,t)+log S 0(λi)+log[1+γ(λi)(T Di(t)−25° C.)] (25)
Considering the fact that S0 (λi) is a constant and that detector temperature TDi(t) remains almost constant during the very short data acquisition time interval of approximately one second, one obtains:
σ[log I D(λi ,t)]=σ[log P(λi ,t)] (26)
As such, the uncertainty caused by detector temperature TDi(t) is eliminated by the use of this standard deviation methodology.
Voltage Detection Mode
σ[log I D(λi ,t)]=σ[log P(λi ,t)] (26)
As such, the uncertainty caused by detector temperature TDi(t) is eliminated by the use of this standard deviation methodology.
Voltage Detection Mode
In the device configuration shown in FIG. 2 , the photocurrent of ith photodiode detector ID(λi,t) is typically converted into a voltage using a preamplifier before digitization. FIG. 4 shows the schematic circuit diagram of a typical preamplifier, which is generally indicated by numeral 400.
The output voltage 412 of ith preamplifier 400, in coupling with ith photodiode detector 408, can be expressed as:
V i(t)=R i I D(λi ,t)=R 0i[1±χi(T Ri(t)−25° C.)]I D(λi ,t) (27)
V i(t)=R i I D(λi ,t)=R 0i[1±χi(T Ri(t)−25° C.)]I D(λi ,t) (27)
In the above Equation (27), R oi is the resistance value of feedback resistor 402 tier ith preamplifier at 25° C., χi is the temperature coefficient of the resistor, and TRi(t) is the temperature of the resistor. Applying common logarithm to both side of the Equation (27), one obtains:
log V i(t)=log R i0+log[1+χi(T Ri(t)−25° C.)]+log I D(λi ,t) (28)
log V i(t)=log R i0+log[1+χi(T Ri(t)−25° C.)]+log I D(λi ,t) (28)
Considering the fact that R oi is a constant and that the resistor temperature TRi(t) does not change during the very short data acquisition time interval of approximately one second, one obtains:
σ[log V i(t)]=σ[log I D(λi ,t)] (29)
Substituting Equation (26) into Equation (29), one obtains:
σ[log V i(t)]=σ[log P(λi ,t)] (30)
As such, the uncertainty caused by resistor temperature TR(t) is eliminated.
σ[log V i(t)]=σ[log I D(λi ,t)] (29)
Substituting Equation (26) into Equation (29), one obtains:
σ[log V i(t)]=σ[log P(λi ,t)] (30)
As such, the uncertainty caused by resistor temperature TR(t) is eliminated.
Under the voltage detection mode, the normalization factor in Equation (18) can be expressed as:
The mathematic correlation between optical measurement and blood glucose concentration can then be established according to Equation (19) or Equation (20), under corresponding calibration conditions.
Similarly, the ratio factor defined by Equation (21) can be expressed as:
The mathematic correlation between optical measurement and blood glucose concentration can then be established according to Equation (22) or Equation (23), under corresponding calibration conditions. The schematic circuit diagram of a typical preamplifier 400 also includes a feedback capacitor 404, an operational amplifier 406, and a ground connection 410.
Digitization
The voltage output 412 from the preamplifier 400 is usually digitized using an analog-to-digital convertor (ADC). The digitized signal is then sent to a computer fir data analysis. The output of ith ADC, in communication with ith preamplifier that is in coupling with ith photodiode 408 collecting light power at wavelength λi, can be expressed by the following Equation:
(ADC)i=(ADC)0i +G i {└I D(λi ,t)+I Dark,i ┘R i +A 0i} (33)
(ADC)i=(ADC)0i +G i {└I D(λi ,t)+I Dark,i ┘R i +A 0i} (33)
In the above Equation (33), (ADC)0i is the offset of ith ADC, Gi is the nominal ADC Gain used during the detection, ID(λi,t) is the photocurrent of ith photodiode detector, IDark,i is the dark current of ith photodiode detector, Ri=R0i[1+χi(TRi(t)−25° C.)]] is the resistance of feedback resistor of ith preamplifier, and A0i is the offset of ith preamplifier.
The contribution of the three factors, (ADC)0i, IDark,i, and A0i can be removed by carrying out a dark measurement with the light source turned off right before or after the corresponding finger measurement. When the light source is turned off, the above Equation (33) becomes:
(ADC)Dark,i=(ADC)0i +G i(I Dark,i R i +A 0i) (34)
(ADC)Dark,i=(ADC)0i +G i(I Dark,i R i +A 0i) (34)
The difference between the two above Equations (33) and (34) reflects ADC output corresponding to the photocurrent:
Δ(ADC)i=(ADC)i−(ADC)Dark,i =G i I D(λi ,t) (35)
Applying common logarithm to both side of the Equation (35), one obtains:
log Δ(ADC)i=log G i+log I D(Δi ,t)+log R i (36)
Δ(ADC)i=(ADC)i−(ADC)Dark,i =G i I D(λi ,t) (35)
Applying common logarithm to both side of the Equation (35), one obtains:
log Δ(ADC)i=log G i+log I D(Δi ,t)+log R i (36)
Gi and Ri can be considered as constants as long as the thine interval between the finger measurement and the dark measurement is short. As such, one obtains:
σ[log Δ(ADC)i]=σ[log I D(λi ,t)] (37)
Substituting Equation (26) into Equation (37), one further obtains:
σ[log Δ(ADC)i]=σ[log P(λi ,t)] (38)
σ[log Δ(ADC)i]=σ[log I D(λi ,t)] (37)
Substituting Equation (26) into Equation (37), one further obtains:
σ[log Δ(ADC)i]=σ[log P(λi ,t)] (38)
Based on Equation (37), the normalization factor defined by Equation (18) can be expressed as:
The mathematic correlation between optical measurement and blood glucose concentration can then be established according to Equation (19) or (20), under corresponding calibration conditions.
Similar to normalization, the ratio factor defined by Equation (21) can be expressed as:
The correlation between optical measurement and blood glucose concentration can then be established according to Equations (22) or (23), under corresponding calibration conditions.
Thus, there has been shown and described several embodiments of a novel invention. As is evident from the foregoing description, certain aspects of the present invention are not limited by the particular details of the examples illustrated herein, and it is therefore contemplated that other modifications and applications, or equivalents thereof, will occur to those skilled in the art. The terms “have,” “having,” “includes,” “including,” and similar terms as used in the foregoing specification are used in the sense of “optional” or “may include” and not as “required.” Many changes, modifications, variations and other uses and applications of the present construction will, however, become apparent to those skilled in the art after considering the specification and the accompanying drawings. All such changes, modifications, variations and other uses and applications, which do not depart from the spirit and scope of the invention, are deemed to be covered by the invention, which is limited only by the claims that follow. It should be understood that the embodiments disclosed herein include any and all combinations of features described in any of the dependent claims.
Claims (6)
1. A system for detecting glucose in a biological sample, comprising:
at least one light source configured to generate one or more light beams to strike a target area of a sample;
at least one light detector positioned to receive light from the at least one light source and to generate an output signal, comprising a time dependent current, which is indicative of a power of light detected;
a light absorbance change determining algorithm implemented processor programmed to calculate a change in a light absorption caused by blood in the biological sample and configured to receive the output signal from the at least one light detector and based on the received output signal, calculate the attenuance attributable to blood in a sample present in the target area with either a normalization factor or a ratio factor, eliminate effect of uncertainty caused by temperature dependent detector response of the at least one light detector, and based on the calculated attenuance, determine a blood glucose level associated with a sample present in the target area;
an analog-to-digital converter comprising a digitized voltage output, wherein the light absorbance change determining algorithm implemented processor is configured to calculate the normalization factor Qi(C,T) based on an analog-to-digital converter voltage output Δ(ADC)i of an ith analog-to-digital converter, where σ is a standard deviation according to an equation:
or a ratio factor Yij(C,T) based on the analog-to-digital converter voltage output Δ(ADC)i of the ith analog-to-digital converter and an analog-to-digital converter voltage output Δ(ADC)j of a jth analog-to-digital converter, where σ is a standard deviation according to the equation:
wherein T is a temperature of the biological sample and C is a concentration of blood glucose in the biological sample.
2. The system for detecting glucose in a biological sample according to claim 1 , wherein the light absorbance change determining algorithm implemented processor is configured to eliminate the effect of uncertainty caused by temperature dependent detector response of the at least one light detector by calculating a standard deviation of the logarithm of the time dependent output current generated by the light power from the same target area of the biological sample.
3. The system for detecting glucose in a biological sample according to claim 1 , wherein the at least one light detector includes a preamplifier comprising a feedback resistor.
4. A system for detecting glucose in a biological sample comprising:
at least one light source configured to generate one or more light beams to strike a target area of a sample;
at least one light detector positioned to receive light from the at least one light source and to generate an output signal, comprising a time dependent current, which is indicative of avower of light detected;
a light absorbance change determining algorithm implemented processor programmed to calculate a change in a light absorption caused by blood in the biological sample and configured to receive the output signal from the at least one light detector and based on the received output signal, calculate the attenuance attributable to blood in a sample present in the target area with either a normalization factor or a ratio factor, eliminate effect of uncertainty caused by temperature dependent detector response of the at least one light detector, and based on the calculated attenuance, determine a blood glucose level associated with a sample present in the target area; and
an analog-to-digital convertor comprising a digitized voltage output, wherein the light absorbance change determining algorithm implemented processor is configured to calculate the normalization factor Qi(C,T) based on the analog-to-digital convertor voltage output Δ(ADC), of the ith analog-to-digital converter, where σ is standard deviation according to an equation:
or a ratio factor Yij(C,T) based on the analog-to-digital convertor voltage output Δ(ADC)i of the ith analog-to-digital convertor and the analog-to-digital convertor voltage output Δ(ADC), of the jth analog-to-digital convertor, where σ is standard deviation according to an equation:
wherein T is the temperature of the biological sample and C is the concentration of blood glucose in the biological sample.
5. A system for detecting glucose in a biological sample comprising:
at least one light source configured to generate one or more light beams to strike a target area of a sample;
at least one light detector positioned to receive light from the at least one light source and to generate an output signal, comprising a time dependent current, which is indicative of a power of light detected;
a light absorbance change determining algorithm implemented processor programmed to calculate a change in a light absorption caused by blood in the biological sample and configured to receive the output signal from the at least one light detector and based on the received output signal, calculate the attenuance attributable to blood in a sample present in the target area, eliminate effect of uncertainty caused by temperature dependent detector response of the at least one light detector, and based on the calculated attenuance, determine a blood glucose level associated with a sample present in the target area; and
an analog-to-digital convertor comprising a digitized voltage output, wherein the light absorbance change determining algorithm implemented processor is configured to eliminate the effect of uncertainty caused by temperature dependent detector response of the at least one light detector by calculating a standard deviation of the logarithm of the time dependent output current generated by the light power from the same target area of the biological sample, wherein the light absorbance change determining algorithm implemented processor is configured to calculate a normalization factor Qi(C,T) based on the analog-to-digital convertor voltage output Δ(ADC), of the ith analog-to-digital converter, where σ is standard deviation according to an equation:
or a ratio factor Yij(C,T) based on the analog-to-digital convertor voltage output Δ(ADC)i of the ith analog-to-digital convertor and the analog-to-digital convertor voltage output Δ(ADC)j of the jth analog-to-digital convertor, where σ is standard deviation according to the equation:
wherein T is the temperature of the biological sample and C is the concentration of blood glucose in the biological sample.
6. The system for detecting glucose in a biological sample according to claim 5 , wherein the at least one light detector includes a preamplifier comprising a feedback resistor.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/227,131 US12036019B2 (en) | 2021-04-09 | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5530308P | 2008-05-22 | 2008-05-22 | |
US8915208P | 2008-08-15 | 2008-08-15 | |
US12/425,535 US8340738B2 (en) | 2008-05-22 | 2009-04-17 | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
US13/610,423 US9629576B2 (en) | 2008-05-22 | 2012-09-11 | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
US15/464,253 US9877670B2 (en) | 2008-05-22 | 2017-03-20 | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
US15/878,268 US10973442B2 (en) | 2008-05-22 | 2018-01-23 | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
US17/227,131 US12036019B2 (en) | 2021-04-09 | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/878,268 Continuation US10973442B2 (en) | 2008-05-22 | 2018-01-23 | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
Publications (2)
Publication Number | Publication Date |
---|---|
US20210228117A1 US20210228117A1 (en) | 2021-07-29 |
US12036019B2 true US12036019B2 (en) | 2024-07-16 |
Family
ID=
Citations (180)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2441343A (en) | 1944-07-07 | 1948-05-11 | Borg Warner | Photoelectric ring gauge |
GB810256A (en) | 1957-05-31 | 1959-03-11 | Sunbeam Mfg Company Ltd | Improvements in or relating to means for varying the optical nature of a beam emitted by a source of light |
US3621268A (en) | 1967-12-19 | 1971-11-16 | Int Standard Electric Corp | Reflection type contactless touch switch having housing with light entrance and exit apertures opposite and facing |
US3910701A (en) | 1973-07-30 | 1975-10-07 | George R Henderson | Method and apparatus for measuring light reflectance absorption and or transmission |
US3954560A (en) | 1970-05-06 | 1976-05-04 | Commissariat A L'energie Atomique | Nuclear fuel assembly |
US3963327A (en) | 1973-11-23 | 1976-06-15 | Ulnic France | Device for operating frusto-conical optical concentrators |
US4014321A (en) | 1974-11-25 | 1977-03-29 | March Wayne F | Non-invasive glucose sensor system |
JPS56156138A (en) | 1980-04-30 | 1981-12-02 | Matsushita Electric Works Ltd | Pulse detecting sensor |
EP0160768A1 (en) | 1984-05-04 | 1985-11-13 | Kurabo Industries Ltd. | Spectrophotometric apparatus for the non-invasive determination of glucose in body tissues |
SU1193541A1 (en) | 1981-01-14 | 1985-11-23 | Краснодарское Отделение Всесоюзного Ордена Трудового Красного Знамени Научно-Исследовательского Института Источников Тока | Photometer |
US4632559A (en) | 1982-11-29 | 1986-12-30 | Miles Laboratories, Inc. | Optical readhead |
US4655225A (en) | 1985-04-18 | 1987-04-07 | Kurabo Industries Ltd. | Spectrophotometric method and apparatus for the non-invasive |
US4781195A (en) | 1987-12-02 | 1988-11-01 | The Boc Group, Inc. | Blood monitoring apparatus and methods with amplifier input dark current correction |
US4836782A (en) | 1983-05-06 | 1989-06-06 | Dentsply Research & Development Corp. | Method for providing direct cool beam incident light on dental target |
JPH02191434A (en) | 1989-01-19 | 1990-07-27 | Ketsuto Kagaku Kenkyusho:Kk | Method and apparatus for near infrared quantitative analysis of blood sugar level |
US4962311A (en) | 1988-05-28 | 1990-10-09 | Messerschmitt-Bolkow-Blohm Gmbh | Device for determining the direction of incident laser radiation |
US4997769A (en) | 1985-06-21 | 1991-03-05 | Radiometer A/S | Method and an apparatus for determining blood components |
US5009230A (en) | 1988-05-31 | 1991-04-23 | Eol, Inc. | Personal glucose monitor |
WO1991015992A1 (en) | 1990-04-19 | 1991-10-31 | Worcester Polytechnic Institute | Method and apparatus for measuring the concentration of absorbing substances |
WO1991015991A1 (en) | 1990-04-19 | 1991-10-31 | Worcester Polytechnic Institute | Method and apparatus for monitoring blood analytes noninvasively by pulsatile photoplethysmography |
US5077476A (en) | 1990-06-27 | 1991-12-31 | Futrex, Inc. | Instrument for non-invasive measurement of blood glucose |
WO1992000513A1 (en) | 1990-06-27 | 1992-01-09 | Futrex, Inc. | Non-invasive measurement of blood glucose |
US5086229A (en) | 1989-01-19 | 1992-02-04 | Futrex, Inc. | Non-invasive measurement of blood glucose |
US5167228A (en) | 1987-06-26 | 1992-12-01 | Brigham And Women's Hospital | Assessment and modification of endogenous circadian phase and amplitude |
WO1993000856A1 (en) | 1991-07-03 | 1993-01-21 | Vivascan Corporation | A non-invasive method and apparatus for measuring concentration of analytes in living tissue |
WO1993006774A1 (en) | 1991-10-03 | 1993-04-15 | Medtronic, Inc. | Method and apparatus for determining hematocrit in blood |
US5222496A (en) | 1990-02-02 | 1993-06-29 | Angiomedics Ii, Inc. | Infrared glucose sensor |
WO1993016629A1 (en) | 1992-02-28 | 1993-09-02 | Cadell Theodore E | Non-invasive device and method for determining concentrations of various components of blood or tissue |
US5255171A (en) | 1991-11-27 | 1993-10-19 | Clark L Douglas | Colored light source providing intensification of initial source illumination |
US5282473A (en) | 1992-11-10 | 1994-02-01 | Critikon, Inc. | Sidestream infrared gas analyzer requiring small sample volumes |
WO1994013199A1 (en) | 1992-12-10 | 1994-06-23 | Sunshine Medical Instruments, Inc. | Non-invasive blood glucose measurement |
WO1994016614A1 (en) | 1993-01-28 | 1994-08-04 | Braig James R | Noninvasive pulsed infrared spectrophotometer |
US5361758A (en) | 1988-06-09 | 1994-11-08 | Cme Telemetrix Inc. | Method and device for measuring concentration levels of blood constituents non-invasively |
WO1995005599A1 (en) | 1993-08-16 | 1995-02-23 | Eli Lilly And Company | Non-invasive near-infrared quantitative measurement instrument |
JPH0788105A (en) | 1993-09-22 | 1995-04-04 | Kowa Co | Pulse wave spectrometer |
US5423983A (en) | 1994-02-07 | 1995-06-13 | Chiang; Jean | Oil filter with a magnetic unit |
US5448992A (en) | 1992-12-10 | 1995-09-12 | Sunshine Medical Instruments, Inc. | Method and apparatus for non-invasive phase sensitive measurement of blood glucose concentration |
WO1995031930A1 (en) | 1994-05-23 | 1995-11-30 | Optiscan, Inc. | Self-emission noninvasive infrared spectrophotometer |
RU2050545C1 (en) | 1989-04-25 | 1995-12-20 | Миграта Юк Лтд. | Method and photometer for determining glucose contents in full blood |
WO1996004840A1 (en) | 1994-08-17 | 1996-02-22 | Dawood Parker | Non-invasive blood analyte sensor |
US5501648A (en) | 1994-07-15 | 1996-03-26 | Grigoriev; Nikita | Front wheel drive bicycle exercise device |
WO1996017546A1 (en) | 1994-12-09 | 1996-06-13 | Optiscan, Inc. | Self-emission noninvasive infrared spectrophotometer with temperature compensation |
US5529065A (en) | 1993-06-02 | 1996-06-25 | Hamamatsu Photonics K.K. | Method for measuring scattering medium and apparatus for the same |
US5535743A (en) | 1992-12-19 | 1996-07-16 | Boehringer Mannheim Gmbh | Device for the in vivo determination of an optical property of the aqueous humour of the eye |
US5576544A (en) | 1989-01-19 | 1996-11-19 | Futrex, Inc. | Method for providing general calibration for near infrared instruments for measurement of blood glucose |
WO1996039926A1 (en) | 1995-06-07 | 1996-12-19 | Masimo Corporation | Active pulse blood constituent monitoring |
WO1996039927A1 (en) | 1995-06-07 | 1996-12-19 | Blackbox, Inc. | Method for noninvasive intermittent and/or continuous hemoglobin, arterial oxygen content, and hematocrit determination |
WO1996041151A1 (en) | 1995-06-07 | 1996-12-19 | Masimo Corporation | Blood glucose monitoring system |
JPH0956702A (en) | 1995-08-18 | 1997-03-04 | Minolta Co Ltd | Noninvasive measuring apparatus for components in blood |
US5615673A (en) | 1995-03-27 | 1997-04-01 | Massachusetts Institute Of Technology | Apparatus and methods of raman spectroscopy for analysis of blood gases and analytes |
US5643334A (en) | 1995-02-07 | 1997-07-01 | Esc Medical Systems Ltd. | Method and apparatus for the diagnostic and composite pulsed heating and photodynamic therapy treatment |
EP0781527A1 (en) | 1995-11-29 | 1997-07-02 | Instrumentarium Oy | Pulsoximeter sensor |
US5666956A (en) | 1996-05-20 | 1997-09-16 | Buchert; Janusz Michal | Instrument and method for non-invasive monitoring of human tissue analyte by measuring the body's infrared radiation |
US5671301A (en) | 1992-12-10 | 1997-09-23 | Sunshine Medical Instruments, Inc. | Optical phase modulator for high resolution phase measurements |
US5703364A (en) | 1996-02-15 | 1997-12-30 | Futrex, Inc. | Method and apparatus for near-infrared quantitative analysis |
WO1998003847A2 (en) | 1996-07-19 | 1998-01-29 | Mills Alexander K | Device for noninvasive determination of blood parameters |
WO1998036681A1 (en) | 1997-02-20 | 1998-08-27 | Emerging Technology Systems, Llc | Non-invasive glucose measuring device and method for measuring blood glucose |
JPH1137931A (en) | 1997-07-14 | 1999-02-12 | Tokimec Inc | Absorptiometer |
WO1999016136A1 (en) | 1997-09-25 | 1999-04-01 | University Of Bristol | Optical irradiation device |
JPH11178813A (en) | 1997-12-22 | 1999-07-06 | Matsushita Electric Works Ltd | Method and device for quantitatively determining glucose concentration |
WO1999039631A1 (en) | 1998-02-05 | 1999-08-12 | In-Line Diagnostics Corporation | Method and apparatus for non-invasive blood constituent monitoring |
WO2000001294A1 (en) | 1998-07-04 | 2000-01-13 | Whitland Research Limited | Non-invasive measurement of blood analytes |
US6025597A (en) | 1995-10-17 | 2000-02-15 | Optiscan Biomedical Corporation | Non-invasive infrared absorption spectrometer for measuring glucose or other constituents in a human or other body |
US6043492A (en) | 1997-10-27 | 2000-03-28 | Industrial Technology Research Institute | Non-invasive blood glucose meter |
JP2000083933A (en) | 1998-07-17 | 2000-03-28 | Nippon Koden Corp | Instrument for measuring concentration of light absorptive material in vital tissue |
WO2000016688A1 (en) | 1998-09-21 | 2000-03-30 | Essential Medical Devices, Inc. | Non-invasive blood component analyzer |
US6067463A (en) | 1999-01-05 | 2000-05-23 | Abbott Laboratories | Method and apparatus for non-invasively measuring the amount of glucose in blood |
US6097975A (en) | 1998-05-13 | 2000-08-01 | Biosensor, Inc. | Apparatus and method for noninvasive glucose measurement |
US6134458A (en) | 1998-12-15 | 2000-10-17 | Futrex Inc. | Light probe for a near-infrared body chemistry measurement instrument |
US6134460A (en) | 1988-11-02 | 2000-10-17 | Non-Invasive Technology, Inc. | Spectrophotometers with catheters for measuring internal tissue |
US6151517A (en) | 1999-01-22 | 2000-11-21 | Futrex Inc. | Method and apparatus for noninvasive quantitative measurement of blood analytes |
US6167290A (en) | 1999-02-03 | 2000-12-26 | Bayspec, Inc. | Method and apparatus of non-invasive measurement of human/animal blood glucose and other metabolites |
WO2001016578A1 (en) | 1999-08-31 | 2001-03-08 | Cme Telemetrix Inc. | Method for determination of analytes using near infrared, adjacent visible spectrum and an array of longer near infrared wavelengths |
US6205354B1 (en) | 1999-06-18 | 2001-03-20 | University Of Utah | Method and apparatus for noninvasive measurement of carotenoids and related chemical substances in biological tissue |
US6208788B1 (en) | 1998-07-29 | 2001-03-27 | Ultradent Products, Inc. | Apparatus and methods for concentrating light through fiber optic funnels coupled to dental light guides |
US6304767B1 (en) | 1998-02-04 | 2001-10-16 | Polestar Technologies, Inc. | Non-invasive optical measurement of blood hematocrit |
US20010030742A1 (en) | 1999-08-19 | 2001-10-18 | Kramer David M. | Non-focusing optics spectrophotometer, and methods of use |
US6312393B1 (en) | 1996-09-04 | 2001-11-06 | Marcio Marc A. M. Abreu | Contact device for placement in direct apposition to the conjunctive of the eye |
US20010047137A1 (en) | 1998-10-08 | 2001-11-29 | University Of Kentucky Research Foundation, Kentucky Corporation | Methods and apparatus for in vivo identification and characterization of vulnerable atherosclerotic plaques |
WO2001093755A1 (en) | 2000-06-09 | 2001-12-13 | Whitland Research Limited | Monitor for non-invasive measurement of blood analytes |
WO2001096872A2 (en) | 2000-06-11 | 2001-12-20 | Orsense Ltd. | Method and device for measuring concentration of glucose or other substances in blood |
US6337564B2 (en) | 1999-04-13 | 2002-01-08 | Alcoa Inc. | Detecting and classifying hard and soft inclusions in liquid metal |
US20020010563A1 (en) | 1999-06-15 | 2002-01-24 | S. Michael Ratteree | Method for achieving and verifying increased productivity in an industrial process |
US20020016534A1 (en) | 1999-04-06 | 2002-02-07 | Pierre Trepagnier | Non-invasive tissue glucose level monitoring |
US20020019055A1 (en) | 1998-06-24 | 2002-02-14 | Larry R. Brown | Non-invasive transdermal detection of analytes |
US20020038080A1 (en) | 2000-09-26 | 2002-03-28 | Makarewicz Marcy R. | Method and apparatus for minimizing spectral effects attributable to tissue state variations during NIR-based non-invasive blood analyte determination |
US6403944B1 (en) | 1997-03-07 | 2002-06-11 | Abbott Laboratories | System for measuring a biological parameter by means of photoacoustic interaction |
US6412548B1 (en) | 1997-11-28 | 2002-07-02 | Mitsubishi Heavy Industries, Ltd. | Water tube protective refractory structure and method of assembling the same |
US20020091324A1 (en) | 1998-04-06 | 2002-07-11 | Nikiforos Kollias | Non-invasive tissue glucose level monitoring |
US6424849B1 (en) | 1998-10-13 | 2002-07-23 | Medoptix, Inc. | Self-contained method for determining blood glucose levels from an IR beam reflected from the surface of the skin |
RU2188425C2 (en) | 1996-08-09 | 2002-08-27 | Лайфскен Инк. | Device usable in instrument for measuring concentration of substance under study in biological fluid sample |
WO2002082990A1 (en) | 2001-04-11 | 2002-10-24 | Rio Grande Medical Technologies, Inc. | System for non-invasive measurement of glucose in humans |
US20020161289A1 (en) | 2001-04-30 | 2002-10-31 | Hopkins George W. | Detector array for optical spectrographs |
US20020167704A1 (en) | 2001-05-09 | 2002-11-14 | Andreas Kleinhans | Sensor element |
US20030004423A1 (en) | 2000-03-02 | 2003-01-02 | Itamar Medical Ltd. | Method and apparatus for the non-invasive detection of particular sleep-state conditions by monitoring the peripheral vascular system |
WO2003001177A2 (en) | 2001-06-26 | 2003-01-03 | Choon Meng Ting | Method and device for measuring blood sugar level |
US20030023140A1 (en) | 1989-02-06 | 2003-01-30 | Britton Chance | Pathlength corrected oximeter and the like |
EP1281370A2 (en) | 2001-08-03 | 2003-02-05 | Susann Edel | Irradiation device |
WO2003010510A2 (en) | 2001-07-25 | 2003-02-06 | Argose, Inc. | Adjunct quantitative system and method for non-invasive measurement of in vivo analytes |
RU2198402C2 (en) | 2001-03-11 | 2003-02-10 | ГУ Тверская государственная медицинская академия | Method for diagnostics of diabetes mellitus |
US6522903B1 (en) | 2000-10-19 | 2003-02-18 | Medoptix, Inc. | Glucose measurement utilizing non-invasive assessment methods |
US20030055325A1 (en) | 2001-06-29 | 2003-03-20 | Weber Walter M. | Signal component processor |
EP1300712A2 (en) | 2001-10-05 | 2003-04-09 | Nicotech Limited | Optical systems including reflectors |
US20030078504A1 (en) | 2001-06-05 | 2003-04-24 | Lumidigm, Inc. | Spectroscopic cross-channel method and apparatus for improved optical measurements of tissue |
US20030099574A1 (en) | 2001-08-22 | 2003-05-29 | Bentsen James G. | Fluorescence based oxygen sensor systems |
JP2003245265A (en) | 2002-02-25 | 2003-09-02 | Matsushita Electric Works Ltd | Noninvasive blood sugar measuring instrument |
WO2003077756A1 (en) | 2002-03-19 | 2003-09-25 | Federalnoe Gosudarstvennoe Unitarnoe Predpriyatie Nauchno-Issledovatelskiy Institut 'polyus' | Physiological method for defining the state of biological tissue (variants) and diagnostic system for carrying out said method |
WO2003079900A1 (en) | 2002-03-25 | 2003-10-02 | Ken-Ichi Yamakoshi | Noninvasive blood component value measuring instrument and method |
US20040015734A1 (en) | 2002-07-19 | 2004-01-22 | Rahman Mohammad Jahidur | Automatic output delay timing adjustment for programmable glitch filter |
US6684099B2 (en) | 2002-04-04 | 2004-01-27 | Inlight Solutions, Inc. | Apparatus and method for reducing spectral complexity in optical sampling |
US6723048B2 (en) | 1999-12-28 | 2004-04-20 | Pindi Products, Inc. | Method and apparatus for non-invasive analysis of blood glucose |
US6731963B2 (en) | 1999-03-09 | 2004-05-04 | Orsense Ltd. | Device for enhancement and quality improvement of blood-related signals for use in a system for non-invasive measurements of blood-related signals |
US20040087844A1 (en) | 2002-11-01 | 2004-05-06 | Brian Yen | Apparatus and method for pattern delivery of radiation and biological characteristic analysis |
US20040106163A1 (en) | 2002-11-12 | 2004-06-03 | Workman Jerome James | Non-invasive measurement of analytes |
US20040181132A1 (en) | 2003-03-14 | 2004-09-16 | Rosenthal Robert D. | Low-cost method and apparatus for non-invasively measuring blood glucose levels |
JP2004267613A (en) | 2003-03-11 | 2004-09-30 | Olympus Corp | Glucose concentration measuring apparatus |
US20040204865A1 (en) | 2003-01-07 | 2004-10-14 | Samsung Electronics Co., Ltd. | Method of removing abnormal data and blood component spectroscopy analysis system employing the same |
JP2004286475A (en) | 2003-03-19 | 2004-10-14 | Olympus Corp | Apparatus for measuring glucose concentration |
JP2004290544A (en) | 2003-03-28 | 2004-10-21 | Citizen Watch Co Ltd | Blood analyzer |
US20040225205A1 (en) | 2003-05-06 | 2004-11-11 | Orsense Ltd. | Glucose level control method and system |
US20040225206A1 (en) | 2003-05-09 | 2004-11-11 | Kouchnir Mikhail A. | Non-invasive analyte measurement device having increased signal to noise ratios |
US6865408B1 (en) | 2001-04-11 | 2005-03-08 | Inlight Solutions, Inc. | System for non-invasive measurement of glucose in humans |
CN1192665C (en) | 1998-02-11 | 2005-03-09 | 艾利森电话股份有限公司 | Server request including code for customizing service to requesting cellular mobile station |
CN2694097Y (en) | 2004-03-12 | 2005-04-20 | 刘金星 | Lighting bulb using LED as light source |
WO2005045377A2 (en) | 2003-11-06 | 2005-05-19 | Orsense Ltd. | Method and system for non-invasive measurements in a human body |
US20050197790A1 (en) | 2001-12-14 | 2005-09-08 | Sterling Bernhard B. | Method of determining an analyte concentration in a sample from an absorption spectrum |
JP2005283563A (en) | 2004-03-02 | 2005-10-13 | Ccs Inc | Light irradiation device |
US6958039B2 (en) | 2003-05-02 | 2005-10-25 | Oculir, Inc. | Method and instruments for non-invasive analyte measurement |
US20050256384A1 (en) | 2004-05-11 | 2005-11-17 | Nostix Llc | Noninvasive glucose sensor |
US6968222B2 (en) | 2003-05-02 | 2005-11-22 | Oculir, Inc. | Methods and device for non-invasive analyte measurement |
US20050261560A1 (en) | 2001-04-11 | 2005-11-24 | Ridder Trent D | Noninvasive determination of alcohol in tissue |
US20050272987A1 (en) | 1995-06-07 | 2005-12-08 | Esmaiel Kiani-Azarbayjany | Active pulse blood constituent monitoring |
US20050276072A1 (en) | 2000-06-21 | 2005-12-15 | Fujitsu Display Technologies Corporation | Lighting unit |
US20060004268A1 (en) | 2004-06-30 | 2006-01-05 | Ok-Kyung Cho | Blood sugar level measuring apparatus |
US20060002598A1 (en) | 2003-04-04 | 2006-01-05 | Lumidigm, Inc. | Noninvasive alcohol sensor |
US20060009685A1 (en) | 2004-07-08 | 2006-01-12 | Orsense Ltd. | Device and method for non-invasive optical measurements |
US6993372B2 (en) | 2003-06-03 | 2006-01-31 | Orsense Ltd. | Method and system for use in non-invasive optical measurements of blood parameters |
US20060058622A1 (en) | 2004-08-24 | 2006-03-16 | The General Hospital Corporation | Method and apparatus for imaging of vessel segments |
US7039446B2 (en) | 2001-01-26 | 2006-05-02 | Sensys Medical, Inc. | Indirect measurement of tissue analytes through tissue properties |
US20060092643A1 (en) | 2004-10-29 | 2006-05-04 | Wong Man S | LED light collection and uniform transmission system using a conical reflector with a roughed up inner surface |
US7043289B2 (en) | 1999-12-22 | 2006-05-09 | Orsense Ltd. | Method of optical measurements for determining various parameters of the patient's blood |
US20060152726A1 (en) | 2005-01-13 | 2006-07-13 | The Curators Of The University Of Missouri | Ultrasensitive spectrophotometer |
WO2006086566A2 (en) | 2005-02-09 | 2006-08-17 | Inlight Solutions, Inc. | Methods and apparatuses for noninvasive determinations of analytes |
WO2006094109A1 (en) | 2005-03-01 | 2006-09-08 | Masimo Laboratories, Inc. | Noninvasive multi-parameter patient monitor |
US7107087B2 (en) | 2003-03-17 | 2006-09-12 | Samsung Electronics Co., Ltd. | Method and apparatus for measuring a concentration of a component in a subject |
US20060224057A1 (en) | 2003-10-21 | 2006-10-05 | Oculir, Inc. | Methods for non-invasive analyte measurement |
US20060234386A1 (en) | 2003-04-30 | 2006-10-19 | Mcgill University | Method and system for measuring lactate levels in vivo |
US7133711B2 (en) | 2002-08-07 | 2006-11-07 | Orsense, Ltd. | Method and system for decomposition of multiple channel signals |
US20060250676A1 (en) | 2005-02-23 | 2006-11-09 | Pixtronix, Incorporated | Light concentrating reflective display methods and apparatus |
US20060258918A1 (en) | 2004-04-14 | 2006-11-16 | Oculir, Inc. | Combination Analyte Measurement Device and Method of Use |
US20060264719A1 (en) | 2004-08-11 | 2006-11-23 | Schurman Matthew J | Method for data reduction and calibration of an OCT-based blood glucose monitor |
US20070049811A1 (en) | 2005-08-24 | 2007-03-01 | Nihon Kohden Corporation | Apparatus and method for measuring oxygen saturation in blood |
CN1932840A (en) | 2005-09-16 | 2007-03-21 | 中国科学技术大学 | Multi-modal biological characteristic identification system based on iris and human face |
US7215987B1 (en) | 2005-11-08 | 2007-05-08 | Woolsthorpe Technologies | Method and apparatus for processing signals reflecting physiological characteristics |
US20070112258A1 (en) | 2005-01-21 | 2007-05-17 | Soyemi Olusola O | Standardization methods for correcting spectral differences across multiple spectroscopic instruments |
JP2007185348A (en) | 2006-01-13 | 2007-07-26 | Olympus Corp | Bio-information detector |
US20070179367A1 (en) | 2000-05-02 | 2007-08-02 | Ruchti Timothy L | Method and Apparatus for Noninvasively Estimating a Property of an Animal Body Analyte from Spectral Data |
US7254432B2 (en) | 2005-08-17 | 2007-08-07 | Orsense Ltd. | Method and device for non-invasive measurements of blood parameters |
WO2007122557A2 (en) | 2006-04-21 | 2007-11-01 | Philips Intellectual Property & Standards Gmbh | Non-invasive glucose sensor |
WO2008014890A1 (en) | 2006-08-04 | 2008-02-07 | Nirlus Engineering Ag | Method for the glucose concentration in pulsational blood |
WO2008039195A1 (en) | 2006-09-27 | 2008-04-03 | Woolsthorpe Technologies, Llc | Pulse amplitude indexing method and apparatus |
US20080137066A1 (en) | 2006-12-12 | 2008-06-12 | Orsense Ltd. | Method and apparatus for determination of analyte concentration |
US20080144004A1 (en) | 2006-12-15 | 2008-06-19 | Futrex Inc. | Optical Spectrophotometer |
US7409239B2 (en) | 2005-05-05 | 2008-08-05 | The Hong Kong Polytechnic University | Method for predicting the blood glucose level of a person |
US20080194014A1 (en) | 2003-06-23 | 2008-08-14 | Applera Corporation | Caps for Sample Wells and Microcards for Biological Materials |
US7436511B2 (en) | 1999-01-22 | 2008-10-14 | Sensys Medical, Inc. | Analyte filter method and apparatus |
US20080266900A1 (en) | 2006-08-25 | 2008-10-30 | Philips Lumileds Lighting Company, Llc | Backlight Using LED Parallel to Light Guide Surface |
US20080316488A1 (en) | 2007-06-20 | 2008-12-25 | Vioptix, Inc. | Measuring Cerebral Oxygen Saturation |
US20090059586A1 (en) | 2007-05-21 | 2009-03-05 | Goldeneye, Inc. | LED light recycling cavity with integrated optics |
WO2009035669A1 (en) | 2007-09-13 | 2009-03-19 | The Curators Of The University Of Missouri | Optical device components |
US7509153B2 (en) | 2000-09-26 | 2009-03-24 | Sensys Medical, Inc. | Method and apparatus for control of skin perfusion for indirect glucose measurement |
WO2009045492A1 (en) | 2007-10-04 | 2009-04-09 | The Curators Of The University Of Missouri | Optical device components |
US20090105605A1 (en) | 2003-04-22 | 2009-04-23 | Marcio Marc Abreu | Apparatus and method for measuring biologic parameters |
US20090116017A1 (en) | 2007-10-23 | 2009-05-07 | Zhi Xu | Optical device components |
US20090196025A1 (en) | 2008-02-01 | 2009-08-06 | Disney Enterprises, Inc. | Cone assembly for illuminating cotton candy with multi-colored, diffused light |
US20090247843A1 (en) | 2008-03-25 | 2009-10-01 | The Curators Of The University Of Missouri | Method and System for Non-Invasive Blood Glucose Detection Utilizing Spectral Data of One or More Components Other Than Glucose |
US20090292186A1 (en) | 2008-05-22 | 2009-11-26 | The Curators Of The University Of Missouri | Method and System for Non-Invasive Optical Blood Glucose Detection Utilizing Spectral Data Analysis |
US20100026995A1 (en) | 2008-08-04 | 2010-02-04 | Masimo Laboratories, Inc. | Multi-stream sensor for noninvasive measurement of blood constituents |
US20100252721A1 (en) | 2009-04-01 | 2010-10-07 | The Curators Of The University Of Missouri | Optical spectroscopy device for non-invasive blood glucose detection and associated method of use |
US8272771B2 (en) | 2006-08-09 | 2012-09-25 | Sony Corporation | Backlight device, light source device, lens, electronic apparatus and light guide plate |
Patent Citations (235)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2441343A (en) | 1944-07-07 | 1948-05-11 | Borg Warner | Photoelectric ring gauge |
GB810256A (en) | 1957-05-31 | 1959-03-11 | Sunbeam Mfg Company Ltd | Improvements in or relating to means for varying the optical nature of a beam emitted by a source of light |
US3621268A (en) | 1967-12-19 | 1971-11-16 | Int Standard Electric Corp | Reflection type contactless touch switch having housing with light entrance and exit apertures opposite and facing |
US3954560A (en) | 1970-05-06 | 1976-05-04 | Commissariat A L'energie Atomique | Nuclear fuel assembly |
US3910701A (en) | 1973-07-30 | 1975-10-07 | George R Henderson | Method and apparatus for measuring light reflectance absorption and or transmission |
US3963327A (en) | 1973-11-23 | 1976-06-15 | Ulnic France | Device for operating frusto-conical optical concentrators |
US4014321A (en) | 1974-11-25 | 1977-03-29 | March Wayne F | Non-invasive glucose sensor system |
JPS56156138A (en) | 1980-04-30 | 1981-12-02 | Matsushita Electric Works Ltd | Pulse detecting sensor |
SU1193541A1 (en) | 1981-01-14 | 1985-11-23 | Краснодарское Отделение Всесоюзного Ордена Трудового Красного Знамени Научно-Исследовательского Института Источников Тока | Photometer |
US4632559A (en) | 1982-11-29 | 1986-12-30 | Miles Laboratories, Inc. | Optical readhead |
US4836782A (en) | 1983-05-06 | 1989-06-06 | Dentsply Research & Development Corp. | Method for providing direct cool beam incident light on dental target |
EP0160768A1 (en) | 1984-05-04 | 1985-11-13 | Kurabo Industries Ltd. | Spectrophotometric apparatus for the non-invasive determination of glucose in body tissues |
US4655225A (en) | 1985-04-18 | 1987-04-07 | Kurabo Industries Ltd. | Spectrophotometric method and apparatus for the non-invasive |
US4997769A (en) | 1985-06-21 | 1991-03-05 | Radiometer A/S | Method and an apparatus for determining blood components |
US5167228A (en) | 1987-06-26 | 1992-12-01 | Brigham And Women's Hospital | Assessment and modification of endogenous circadian phase and amplitude |
EP0319159A1 (en) | 1987-12-02 | 1989-06-07 | The Boc Group, Inc. | Blood monitoring apparatus and methods with amplifier input dark current correction |
US4781195A (en) | 1987-12-02 | 1988-11-01 | The Boc Group, Inc. | Blood monitoring apparatus and methods with amplifier input dark current correction |
US4962311A (en) | 1988-05-28 | 1990-10-09 | Messerschmitt-Bolkow-Blohm Gmbh | Device for determining the direction of incident laser radiation |
US5009230A (en) | 1988-05-31 | 1991-04-23 | Eol, Inc. | Personal glucose monitor |
US5361758A (en) | 1988-06-09 | 1994-11-08 | Cme Telemetrix Inc. | Method and device for measuring concentration levels of blood constituents non-invasively |
US6134460A (en) | 1988-11-02 | 2000-10-17 | Non-Invasive Technology, Inc. | Spectrophotometers with catheters for measuring internal tissue |
US5086229A (en) | 1989-01-19 | 1992-02-04 | Futrex, Inc. | Non-invasive measurement of blood glucose |
US5028787A (en) | 1989-01-19 | 1991-07-02 | Futrex, Inc. | Non-invasive measurement of blood glucose |
US5576544A (en) | 1989-01-19 | 1996-11-19 | Futrex, Inc. | Method for providing general calibration for near infrared instruments for measurement of blood glucose |
JPH02191434A (en) | 1989-01-19 | 1990-07-27 | Ketsuto Kagaku Kenkyusho:Kk | Method and apparatus for near infrared quantitative analysis of blood sugar level |
US20030023140A1 (en) | 1989-02-06 | 2003-01-30 | Britton Chance | Pathlength corrected oximeter and the like |
RU2050545C1 (en) | 1989-04-25 | 1995-12-20 | Миграта Юк Лтд. | Method and photometer for determining glucose contents in full blood |
US5183042A (en) | 1989-05-23 | 1993-02-02 | Vivascan Corporation | Electromagnetic method and apparatus to measure constituents of human or animal tissue |
US5222496A (en) | 1990-02-02 | 1993-06-29 | Angiomedics Ii, Inc. | Infrared glucose sensor |
US5112124A (en) | 1990-04-19 | 1992-05-12 | Worcester Polytechnic Institute | Method and apparatus for measuring the concentration of absorbing substances |
WO1991015991A1 (en) | 1990-04-19 | 1991-10-31 | Worcester Polytechnic Institute | Method and apparatus for monitoring blood analytes noninvasively by pulsatile photoplethysmography |
US5137023A (en) | 1990-04-19 | 1992-08-11 | Worcester Polytechnic Institute | Method and apparatus for monitoring blood analytes noninvasively by pulsatile photoplethysmography |
WO1991015992A1 (en) | 1990-04-19 | 1991-10-31 | Worcester Polytechnic Institute | Method and apparatus for measuring the concentration of absorbing substances |
US5077476A (en) | 1990-06-27 | 1991-12-31 | Futrex, Inc. | Instrument for non-invasive measurement of blood glucose |
WO1992000513A1 (en) | 1990-06-27 | 1992-01-09 | Futrex, Inc. | Non-invasive measurement of blood glucose |
WO1993000856A1 (en) | 1991-07-03 | 1993-01-21 | Vivascan Corporation | A non-invasive method and apparatus for measuring concentration of analytes in living tissue |
WO1993006774A1 (en) | 1991-10-03 | 1993-04-15 | Medtronic, Inc. | Method and apparatus for determining hematocrit in blood |
US5255171A (en) | 1991-11-27 | 1993-10-19 | Clark L Douglas | Colored light source providing intensification of initial source illumination |
WO1993016629A1 (en) | 1992-02-28 | 1993-09-02 | Cadell Theodore E | Non-invasive device and method for determining concentrations of various components of blood or tissue |
US5282473A (en) | 1992-11-10 | 1994-02-01 | Critikon, Inc. | Sidestream infrared gas analyzer requiring small sample volumes |
WO1994013199A1 (en) | 1992-12-10 | 1994-06-23 | Sunshine Medical Instruments, Inc. | Non-invasive blood glucose measurement |
US5448992A (en) | 1992-12-10 | 1995-09-12 | Sunshine Medical Instruments, Inc. | Method and apparatus for non-invasive phase sensitive measurement of blood glucose concentration |
US5671301A (en) | 1992-12-10 | 1997-09-23 | Sunshine Medical Instruments, Inc. | Optical phase modulator for high resolution phase measurements |
US5535743A (en) | 1992-12-19 | 1996-07-16 | Boehringer Mannheim Gmbh | Device for the in vivo determination of an optical property of the aqueous humour of the eye |
WO1994016614A1 (en) | 1993-01-28 | 1994-08-04 | Braig James R | Noninvasive pulsed infrared spectrophotometer |
US5615672A (en) | 1993-01-28 | 1997-04-01 | Optiscan, Inc. | Self-emission noninvasive infrared spectrophotometer with body temperature compensation |
US5515847A (en) | 1993-01-28 | 1996-05-14 | Optiscan, Inc. | Self-emission noninvasive infrared spectrophotometer |
US5529065A (en) | 1993-06-02 | 1996-06-25 | Hamamatsu Photonics K.K. | Method for measuring scattering medium and apparatus for the same |
WO1995005599A1 (en) | 1993-08-16 | 1995-02-23 | Eli Lilly And Company | Non-invasive near-infrared quantitative measurement instrument |
US5522388A (en) | 1993-09-22 | 1996-06-04 | Kowa Company Ltd. | Pulse spectrometer |
JPH0788105A (en) | 1993-09-22 | 1995-04-04 | Kowa Co | Pulse wave spectrometer |
US5423983A (en) | 1994-02-07 | 1995-06-13 | Chiang; Jean | Oil filter with a magnetic unit |
WO1995031930A1 (en) | 1994-05-23 | 1995-11-30 | Optiscan, Inc. | Self-emission noninvasive infrared spectrophotometer |
US5501648A (en) | 1994-07-15 | 1996-03-26 | Grigoriev; Nikita | Front wheel drive bicycle exercise device |
WO1996004840A1 (en) | 1994-08-17 | 1996-02-22 | Dawood Parker | Non-invasive blood analyte sensor |
US5553613A (en) | 1994-08-17 | 1996-09-10 | Pfizer Inc. | Non invasive blood analyte sensor |
WO1996017546A1 (en) | 1994-12-09 | 1996-06-13 | Optiscan, Inc. | Self-emission noninvasive infrared spectrophotometer with temperature compensation |
US5643334A (en) | 1995-02-07 | 1997-07-01 | Esc Medical Systems Ltd. | Method and apparatus for the diagnostic and composite pulsed heating and photodynamic therapy treatment |
US5615673A (en) | 1995-03-27 | 1997-04-01 | Massachusetts Institute Of Technology | Apparatus and methods of raman spectroscopy for analysis of blood gases and analytes |
US5743262A (en) | 1995-06-07 | 1998-04-28 | Masimo Corporation | Blood glucose monitoring system |
WO1996041151A1 (en) | 1995-06-07 | 1996-12-19 | Masimo Corporation | Blood glucose monitoring system |
WO1996039927A1 (en) | 1995-06-07 | 1996-12-19 | Blackbox, Inc. | Method for noninvasive intermittent and/or continuous hemoglobin, arterial oxygen content, and hematocrit determination |
WO1996039926A1 (en) | 1995-06-07 | 1996-12-19 | Masimo Corporation | Active pulse blood constituent monitoring |
US20050272987A1 (en) | 1995-06-07 | 2005-12-08 | Esmaiel Kiani-Azarbayjany | Active pulse blood constituent monitoring |
EP0830582B1 (en) | 1995-06-07 | 2005-08-17 | Masimo Corporation | Blood glucose monitoring system |
JPH0956702A (en) | 1995-08-18 | 1997-03-04 | Minolta Co Ltd | Noninvasive measuring apparatus for components in blood |
US6025597A (en) | 1995-10-17 | 2000-02-15 | Optiscan Biomedical Corporation | Non-invasive infrared absorption spectrometer for measuring glucose or other constituents in a human or other body |
EP0781527A1 (en) | 1995-11-29 | 1997-07-02 | Instrumentarium Oy | Pulsoximeter sensor |
US5703364A (en) | 1996-02-15 | 1997-12-30 | Futrex, Inc. | Method and apparatus for near-infrared quantitative analysis |
US5666956A (en) | 1996-05-20 | 1997-09-16 | Buchert; Janusz Michal | Instrument and method for non-invasive monitoring of human tissue analyte by measuring the body's infrared radiation |
WO1998003847A2 (en) | 1996-07-19 | 1998-01-29 | Mills Alexander K | Device for noninvasive determination of blood parameters |
RU2188425C2 (en) | 1996-08-09 | 2002-08-27 | Лайфскен Инк. | Device usable in instrument for measuring concentration of substance under study in biological fluid sample |
US6312393B1 (en) | 1996-09-04 | 2001-11-06 | Marcio Marc A. M. Abreu | Contact device for placement in direct apposition to the conjunctive of the eye |
WO1998036681A1 (en) | 1997-02-20 | 1998-08-27 | Emerging Technology Systems, Llc | Non-invasive glucose measuring device and method for measuring blood glucose |
US6775564B1 (en) | 1997-02-20 | 2004-08-10 | Lifetrac Systems, Inc. | Non-invasive glucose measuring device and method for measuring blood glucose |
US5910109A (en) | 1997-02-20 | 1999-06-08 | Emerging Technology Systems, Llc | Non-invasive glucose measuring device and method for measuring blood glucose |
US6833540B2 (en) | 1997-03-07 | 2004-12-21 | Abbott Laboratories | System for measuring a biological parameter by means of photoacoustic interaction |
US6403944B1 (en) | 1997-03-07 | 2002-06-11 | Abbott Laboratories | System for measuring a biological parameter by means of photoacoustic interaction |
JPH1137931A (en) | 1997-07-14 | 1999-02-12 | Tokimec Inc | Absorptiometer |
WO1999016136A1 (en) | 1997-09-25 | 1999-04-01 | University Of Bristol | Optical irradiation device |
US6043492A (en) | 1997-10-27 | 2000-03-28 | Industrial Technology Research Institute | Non-invasive blood glucose meter |
US6412548B1 (en) | 1997-11-28 | 2002-07-02 | Mitsubishi Heavy Industries, Ltd. | Water tube protective refractory structure and method of assembling the same |
JPH11178813A (en) | 1997-12-22 | 1999-07-06 | Matsushita Electric Works Ltd | Method and device for quantitatively determining glucose concentration |
US6304767B1 (en) | 1998-02-04 | 2001-10-16 | Polestar Technologies, Inc. | Non-invasive optical measurement of blood hematocrit |
US6873865B2 (en) | 1998-02-05 | 2005-03-29 | Hema Metrics, Inc. | Method and apparatus for non-invasive blood constituent monitoring |
US6671528B2 (en) | 1998-02-05 | 2003-12-30 | Hema Metrics, Inc. | Method and apparatus for non-invasive blood constituent monitoring |
US20040127779A1 (en) | 1998-02-05 | 2004-07-01 | Steuer Robert R. | Method and apparatus for non-invasive blood constituent monitoring |
WO1999039631A1 (en) | 1998-02-05 | 1999-08-12 | In-Line Diagnostics Corporation | Method and apparatus for non-invasive blood constituent monitoring |
US20010039376A1 (en) | 1998-02-05 | 2001-11-08 | Steuer Robert R. | Method and apparatus for non-invasive blood constituent monitoring |
US6181958B1 (en) | 1998-02-05 | 2001-01-30 | In-Line Diagnostics Corporation | Method and apparatus for non-invasive blood constituent monitoring |
CN1192665C (en) | 1998-02-11 | 2005-03-09 | 艾利森电话股份有限公司 | Server request including code for customizing service to requesting cellular mobile station |
US20020091324A1 (en) | 1998-04-06 | 2002-07-11 | Nikiforos Kollias | Non-invasive tissue glucose level monitoring |
US6097975A (en) | 1998-05-13 | 2000-08-01 | Biosensor, Inc. | Apparatus and method for noninvasive glucose measurement |
US20020019055A1 (en) | 1998-06-24 | 2002-02-14 | Larry R. Brown | Non-invasive transdermal detection of analytes |
EP1094745A1 (en) | 1998-07-04 | 2001-05-02 | Whitland Research Limited | Non-invasive measurement of blood analytes |
US20050131286A1 (en) | 1998-07-04 | 2005-06-16 | Edwards Lifesciences | Non-invasive measurement of blood analytes |
US6990365B1 (en) | 1998-07-04 | 2006-01-24 | Edwards Lifesciences | Apparatus for measurement of blood analytes |
WO2000001294A1 (en) | 1998-07-04 | 2000-01-13 | Whitland Research Limited | Non-invasive measurement of blood analytes |
US7424317B2 (en) | 1998-07-04 | 2008-09-09 | Edwards Lifesciences | Non-invasive measurement of blood analytes |
JP2000083933A (en) | 1998-07-17 | 2000-03-28 | Nippon Koden Corp | Instrument for measuring concentration of light absorptive material in vital tissue |
US6208788B1 (en) | 1998-07-29 | 2001-03-27 | Ultradent Products, Inc. | Apparatus and methods for concentrating light through fiber optic funnels coupled to dental light guides |
US6064898A (en) | 1998-09-21 | 2000-05-16 | Essential Medical Devices | Non-invasive blood component analyzer |
WO2000016688A1 (en) | 1998-09-21 | 2000-03-30 | Essential Medical Devices, Inc. | Non-invasive blood component analyzer |
US20010047137A1 (en) | 1998-10-08 | 2001-11-29 | University Of Kentucky Research Foundation, Kentucky Corporation | Methods and apparatus for in vivo identification and characterization of vulnerable atherosclerotic plaques |
US6424851B1 (en) | 1998-10-13 | 2002-07-23 | Medoptix, Inc. | Infrared ATR glucose measurement system (II) |
US6424848B1 (en) | 1998-10-13 | 2002-07-23 | Medoptix, Inc. | Method for preparing skin surface and determining glucose levels from that surface |
US6424849B1 (en) | 1998-10-13 | 2002-07-23 | Medoptix, Inc. | Self-contained method for determining blood glucose levels from an IR beam reflected from the surface of the skin |
US6430424B1 (en) | 1998-10-13 | 2002-08-06 | Medoptix, Inc. | Infrared ATR glucose measurement system utilizing a single surface of skin |
US6445938B1 (en) | 1998-10-13 | 2002-09-03 | Medoptix, Inc. | Method for determining blood glucose levels from a single surface of the skin |
US6134458A (en) | 1998-12-15 | 2000-10-17 | Futrex Inc. | Light probe for a near-infrared body chemistry measurement instrument |
US6067463A (en) | 1999-01-05 | 2000-05-23 | Abbott Laboratories | Method and apparatus for non-invasively measuring the amount of glucose in blood |
US7436511B2 (en) | 1999-01-22 | 2008-10-14 | Sensys Medical, Inc. | Analyte filter method and apparatus |
US6151517A (en) | 1999-01-22 | 2000-11-21 | Futrex Inc. | Method and apparatus for noninvasive quantitative measurement of blood analytes |
US6167290A (en) | 1999-02-03 | 2000-12-26 | Bayspec, Inc. | Method and apparatus of non-invasive measurement of human/animal blood glucose and other metabolites |
US6731963B2 (en) | 1999-03-09 | 2004-05-04 | Orsense Ltd. | Device for enhancement and quality improvement of blood-related signals for use in a system for non-invasive measurements of blood-related signals |
US20020016534A1 (en) | 1999-04-06 | 2002-02-07 | Pierre Trepagnier | Non-invasive tissue glucose level monitoring |
US6337564B2 (en) | 1999-04-13 | 2002-01-08 | Alcoa Inc. | Detecting and classifying hard and soft inclusions in liquid metal |
US20020010563A1 (en) | 1999-06-15 | 2002-01-24 | S. Michael Ratteree | Method for achieving and verifying increased productivity in an industrial process |
US6205354B1 (en) | 1999-06-18 | 2001-03-20 | University Of Utah | Method and apparatus for noninvasive measurement of carotenoids and related chemical substances in biological tissue |
US20010030742A1 (en) | 1999-08-19 | 2001-10-18 | Kramer David M. | Non-focusing optics spectrophotometer, and methods of use |
WO2001016578A1 (en) | 1999-08-31 | 2001-03-08 | Cme Telemetrix Inc. | Method for determination of analytes using near infrared, adjacent visible spectrum and an array of longer near infrared wavelengths |
US7043289B2 (en) | 1999-12-22 | 2006-05-09 | Orsense Ltd. | Method of optical measurements for determining various parameters of the patient's blood |
US20060200014A1 (en) | 1999-12-22 | 2006-09-07 | Orsense Ltd. | Method of optical measurements for determining various parameters of the patient's blood |
US6723048B2 (en) | 1999-12-28 | 2004-04-20 | Pindi Products, Inc. | Method and apparatus for non-invasive analysis of blood glucose |
US20030004423A1 (en) | 2000-03-02 | 2003-01-02 | Itamar Medical Ltd. | Method and apparatus for the non-invasive detection of particular sleep-state conditions by monitoring the peripheral vascular system |
US20070179367A1 (en) | 2000-05-02 | 2007-08-02 | Ruchti Timothy L | Method and Apparatus for Noninvasively Estimating a Property of an Animal Body Analyte from Spectral Data |
WO2001093755A1 (en) | 2000-06-09 | 2001-12-13 | Whitland Research Limited | Monitor for non-invasive measurement of blood analytes |
WO2001096872A2 (en) | 2000-06-11 | 2001-12-20 | Orsense Ltd. | Method and device for measuring concentration of glucose or other substances in blood |
US6804002B2 (en) | 2000-06-11 | 2004-10-12 | Orsense Ltd. | Method and device for measuring concentration of glucose or other substances in blood |
US20050276072A1 (en) | 2000-06-21 | 2005-12-15 | Fujitsu Display Technologies Corporation | Lighting unit |
US7509153B2 (en) | 2000-09-26 | 2009-03-24 | Sensys Medical, Inc. | Method and apparatus for control of skin perfusion for indirect glucose measurement |
US20020038080A1 (en) | 2000-09-26 | 2002-03-28 | Makarewicz Marcy R. | Method and apparatus for minimizing spectral effects attributable to tissue state variations during NIR-based non-invasive blood analyte determination |
US7039447B2 (en) | 2000-10-19 | 2006-05-02 | Vivomedical, Inc. | Glucose measurement utilizing non-invasive assessment methods |
US6522903B1 (en) | 2000-10-19 | 2003-02-18 | Medoptix, Inc. | Glucose measurement utilizing non-invasive assessment methods |
US7039446B2 (en) | 2001-01-26 | 2006-05-02 | Sensys Medical, Inc. | Indirect measurement of tissue analytes through tissue properties |
RU2198402C2 (en) | 2001-03-11 | 2003-02-10 | ГУ Тверская государственная медицинская академия | Method for diagnostics of diabetes mellitus |
US20030023152A1 (en) | 2001-04-11 | 2003-01-30 | Abbink Russell E. | System for non-invasive measurement of glucose in humans |
WO2002082990A1 (en) | 2001-04-11 | 2002-10-24 | Rio Grande Medical Technologies, Inc. | System for non-invasive measurement of glucose in humans |
US6574490B2 (en) | 2001-04-11 | 2003-06-03 | Rio Grande Medical Technologies, Inc. | System for non-invasive measurement of glucose in humans |
US20050261560A1 (en) | 2001-04-11 | 2005-11-24 | Ridder Trent D | Noninvasive determination of alcohol in tissue |
US6865408B1 (en) | 2001-04-11 | 2005-03-08 | Inlight Solutions, Inc. | System for non-invasive measurement of glucose in humans |
US20020161289A1 (en) | 2001-04-30 | 2002-10-31 | Hopkins George W. | Detector array for optical spectrographs |
US20020167704A1 (en) | 2001-05-09 | 2002-11-14 | Andreas Kleinhans | Sensor element |
US20030078504A1 (en) | 2001-06-05 | 2003-04-24 | Lumidigm, Inc. | Spectroscopic cross-channel method and apparatus for improved optical measurements of tissue |
WO2003001177A2 (en) | 2001-06-26 | 2003-01-03 | Choon Meng Ting | Method and device for measuring blood sugar level |
JP2004538054A (en) | 2001-06-26 | 2004-12-24 | メン チン、チューン | Method and device for measuring blood glucose |
US20030055325A1 (en) | 2001-06-29 | 2003-03-20 | Weber Walter M. | Signal component processor |
WO2003010510A2 (en) | 2001-07-25 | 2003-02-06 | Argose, Inc. | Adjunct quantitative system and method for non-invasive measurement of in vivo analytes |
EP1281370A2 (en) | 2001-08-03 | 2003-02-05 | Susann Edel | Irradiation device |
US20030099574A1 (en) | 2001-08-22 | 2003-05-29 | Bentsen James G. | Fluorescence based oxygen sensor systems |
EP1300712A2 (en) | 2001-10-05 | 2003-04-09 | Nicotech Limited | Optical systems including reflectors |
US20050197790A1 (en) | 2001-12-14 | 2005-09-08 | Sterling Bernhard B. | Method of determining an analyte concentration in a sample from an absorption spectrum |
JP2003245265A (en) | 2002-02-25 | 2003-09-02 | Matsushita Electric Works Ltd | Noninvasive blood sugar measuring instrument |
WO2003077756A1 (en) | 2002-03-19 | 2003-09-25 | Federalnoe Gosudarstvennoe Unitarnoe Predpriyatie Nauchno-Issledovatelskiy Institut 'polyus' | Physiological method for defining the state of biological tissue (variants) and diagnostic system for carrying out said method |
US20080027297A1 (en) | 2002-03-25 | 2008-01-31 | Tyt Institute Of Technology Corporation | Non-invasive blood constituent measuring instrument and measuring method |
US20060063983A1 (en) | 2002-03-25 | 2006-03-23 | Ken-Ichi Yamakoshi | Non-invasive blood component value measuring instrument and method |
WO2003079900A1 (en) | 2002-03-25 | 2003-10-02 | Ken-Ichi Yamakoshi | Noninvasive blood component value measuring instrument and method |
US6684099B2 (en) | 2002-04-04 | 2004-01-27 | Inlight Solutions, Inc. | Apparatus and method for reducing spectral complexity in optical sampling |
US20040015734A1 (en) | 2002-07-19 | 2004-01-22 | Rahman Mohammad Jahidur | Automatic output delay timing adjustment for programmable glitch filter |
US7133711B2 (en) | 2002-08-07 | 2006-11-07 | Orsense, Ltd. | Method and system for decomposition of multiple channel signals |
US20070149869A1 (en) | 2002-11-01 | 2007-06-28 | Brian Yen | Apparatus and Method for Pattern Delivery of Radiation and Biological Characteristic Analysis |
US20040087844A1 (en) | 2002-11-01 | 2004-05-06 | Brian Yen | Apparatus and method for pattern delivery of radiation and biological characteristic analysis |
US20040106163A1 (en) | 2002-11-12 | 2004-06-03 | Workman Jerome James | Non-invasive measurement of analytes |
US20040204865A1 (en) | 2003-01-07 | 2004-10-14 | Samsung Electronics Co., Ltd. | Method of removing abnormal data and blood component spectroscopy analysis system employing the same |
JP2004267613A (en) | 2003-03-11 | 2004-09-30 | Olympus Corp | Glucose concentration measuring apparatus |
US20040181132A1 (en) | 2003-03-14 | 2004-09-16 | Rosenthal Robert D. | Low-cost method and apparatus for non-invasively measuring blood glucose levels |
US7107087B2 (en) | 2003-03-17 | 2006-09-12 | Samsung Electronics Co., Ltd. | Method and apparatus for measuring a concentration of a component in a subject |
JP2004286475A (en) | 2003-03-19 | 2004-10-14 | Olympus Corp | Apparatus for measuring glucose concentration |
JP2004290544A (en) | 2003-03-28 | 2004-10-21 | Citizen Watch Co Ltd | Blood analyzer |
US20060002598A1 (en) | 2003-04-04 | 2006-01-05 | Lumidigm, Inc. | Noninvasive alcohol sensor |
US20090105605A1 (en) | 2003-04-22 | 2009-04-23 | Marcio Marc Abreu | Apparatus and method for measuring biologic parameters |
US20060234386A1 (en) | 2003-04-30 | 2006-10-19 | Mcgill University | Method and system for measuring lactate levels in vivo |
US6968222B2 (en) | 2003-05-02 | 2005-11-22 | Oculir, Inc. | Methods and device for non-invasive analyte measurement |
US6958039B2 (en) | 2003-05-02 | 2005-10-25 | Oculir, Inc. | Method and instruments for non-invasive analyte measurement |
US20040225205A1 (en) | 2003-05-06 | 2004-11-11 | Orsense Ltd. | Glucose level control method and system |
US7266400B2 (en) | 2003-05-06 | 2007-09-04 | Orsense Ltd. | Glucose level control method and system |
US20040225206A1 (en) | 2003-05-09 | 2004-11-11 | Kouchnir Mikhail A. | Non-invasive analyte measurement device having increased signal to noise ratios |
US20060129040A1 (en) | 2003-06-03 | 2006-06-15 | Orsense Ltd. | Method and system for use in non-invasive optical measurements of blood parameters |
US6993372B2 (en) | 2003-06-03 | 2006-01-31 | Orsense Ltd. | Method and system for use in non-invasive optical measurements of blood parameters |
US20080194014A1 (en) | 2003-06-23 | 2008-08-14 | Applera Corporation | Caps for Sample Wells and Microcards for Biological Materials |
US20060224057A1 (en) | 2003-10-21 | 2006-10-05 | Oculir, Inc. | Methods for non-invasive analyte measurement |
US20070078312A1 (en) | 2003-11-06 | 2007-04-05 | Orense Ltd. | Method and system for non-invasive measurements in a human body |
WO2005045377A2 (en) | 2003-11-06 | 2005-05-19 | Orsense Ltd. | Method and system for non-invasive measurements in a human body |
JP2005283563A (en) | 2004-03-02 | 2005-10-13 | Ccs Inc | Light irradiation device |
CN2694097Y (en) | 2004-03-12 | 2005-04-20 | 刘金星 | Lighting bulb using LED as light source |
US20060258918A1 (en) | 2004-04-14 | 2006-11-16 | Oculir, Inc. | Combination Analyte Measurement Device and Method of Use |
US20050256384A1 (en) | 2004-05-11 | 2005-11-17 | Nostix Llc | Noninvasive glucose sensor |
US20060004268A1 (en) | 2004-06-30 | 2006-01-05 | Ok-Kyung Cho | Blood sugar level measuring apparatus |
US20060009685A1 (en) | 2004-07-08 | 2006-01-12 | Orsense Ltd. | Device and method for non-invasive optical measurements |
US20060264719A1 (en) | 2004-08-11 | 2006-11-23 | Schurman Matthew J | Method for data reduction and calibration of an OCT-based blood glucose monitor |
US20060058622A1 (en) | 2004-08-24 | 2006-03-16 | The General Hospital Corporation | Method and apparatus for imaging of vessel segments |
US20060092643A1 (en) | 2004-10-29 | 2006-05-04 | Wong Man S | LED light collection and uniform transmission system using a conical reflector with a roughed up inner surface |
US20060152726A1 (en) | 2005-01-13 | 2006-07-13 | The Curators Of The University Of Missouri | Ultrasensitive spectrophotometer |
US20070112258A1 (en) | 2005-01-21 | 2007-05-17 | Soyemi Olusola O | Standardization methods for correcting spectral differences across multiple spectroscopic instruments |
WO2006086566A2 (en) | 2005-02-09 | 2006-08-17 | Inlight Solutions, Inc. | Methods and apparatuses for noninvasive determinations of analytes |
US20060250676A1 (en) | 2005-02-23 | 2006-11-09 | Pixtronix, Incorporated | Light concentrating reflective display methods and apparatus |
WO2006094109A1 (en) | 2005-03-01 | 2006-09-08 | Masimo Laboratories, Inc. | Noninvasive multi-parameter patient monitor |
US20060226992A1 (en) | 2005-03-01 | 2006-10-12 | Ammar Al-Ali | Noninvasive multi-parameter patient monitor |
US7409239B2 (en) | 2005-05-05 | 2008-08-05 | The Hong Kong Polytechnic University | Method for predicting the blood glucose level of a person |
US7254432B2 (en) | 2005-08-17 | 2007-08-07 | Orsense Ltd. | Method and device for non-invasive measurements of blood parameters |
US20070049811A1 (en) | 2005-08-24 | 2007-03-01 | Nihon Kohden Corporation | Apparatus and method for measuring oxygen saturation in blood |
CN1932840A (en) | 2005-09-16 | 2007-03-21 | 中国科学技术大学 | Multi-modal biological characteristic identification system based on iris and human face |
US7215987B1 (en) | 2005-11-08 | 2007-05-08 | Woolsthorpe Technologies | Method and apparatus for processing signals reflecting physiological characteristics |
JP2007185348A (en) | 2006-01-13 | 2007-07-26 | Olympus Corp | Bio-information detector |
WO2007122557A2 (en) | 2006-04-21 | 2007-11-01 | Philips Intellectual Property & Standards Gmbh | Non-invasive glucose sensor |
US20090270700A1 (en) | 2006-04-21 | 2009-10-29 | Koninklijke Philips Electronics N.V. | Non-invasive glucose sensor |
WO2008014890A1 (en) | 2006-08-04 | 2008-02-07 | Nirlus Engineering Ag | Method for the glucose concentration in pulsational blood |
JP2009545344A (en) | 2006-08-04 | 2009-12-24 | ニルラス・エンジニアリング・アクチエンゲゼルシャフト | Method for measuring glucose concentration in pulsing blood |
US8272771B2 (en) | 2006-08-09 | 2012-09-25 | Sony Corporation | Backlight device, light source device, lens, electronic apparatus and light guide plate |
US20080266900A1 (en) | 2006-08-25 | 2008-10-30 | Philips Lumileds Lighting Company, Llc | Backlight Using LED Parallel to Light Guide Surface |
WO2008039195A1 (en) | 2006-09-27 | 2008-04-03 | Woolsthorpe Technologies, Llc | Pulse amplitude indexing method and apparatus |
US20080137066A1 (en) | 2006-12-12 | 2008-06-12 | Orsense Ltd. | Method and apparatus for determination of analyte concentration |
US20080144004A1 (en) | 2006-12-15 | 2008-06-19 | Futrex Inc. | Optical Spectrophotometer |
US20090059586A1 (en) | 2007-05-21 | 2009-03-05 | Goldeneye, Inc. | LED light recycling cavity with integrated optics |
US20080316488A1 (en) | 2007-06-20 | 2008-12-25 | Vioptix, Inc. | Measuring Cerebral Oxygen Saturation |
WO2009035669A1 (en) | 2007-09-13 | 2009-03-19 | The Curators Of The University Of Missouri | Optical device components |
US20090079964A1 (en) | 2007-09-13 | 2009-03-26 | Zhi Xu | Optical device components |
US20090105565A1 (en) | 2007-10-04 | 2009-04-23 | Zhi Xu | Optical device components |
US7809418B2 (en) | 2007-10-04 | 2010-10-05 | The Curators Of The University Of Missouri | Optical device components |
WO2009045492A1 (en) | 2007-10-04 | 2009-04-09 | The Curators Of The University Of Missouri | Optical device components |
US20090116017A1 (en) | 2007-10-23 | 2009-05-07 | Zhi Xu | Optical device components |
US7961305B2 (en) | 2007-10-23 | 2011-06-14 | The Curators Of The University Of Missouri | Optical device components |
US20090196025A1 (en) | 2008-02-01 | 2009-08-06 | Disney Enterprises, Inc. | Cone assembly for illuminating cotton candy with multi-colored, diffused light |
US20090247843A1 (en) | 2008-03-25 | 2009-10-01 | The Curators Of The University Of Missouri | Method and System for Non-Invasive Blood Glucose Detection Utilizing Spectral Data of One or More Components Other Than Glucose |
WO2009120600A2 (en) | 2008-03-25 | 2009-10-01 | The Curators Of The University Of Missouri | Method and system for non-invasive blood glucose detection utilizing spectral data of one or more components other than glucose |
WO2009142853A1 (en) | 2008-05-22 | 2009-11-26 | The Curators Of The University Of Missouri | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
US20090292186A1 (en) | 2008-05-22 | 2009-11-26 | The Curators Of The University Of Missouri | Method and System for Non-Invasive Optical Blood Glucose Detection Utilizing Spectral Data Analysis |
US8340738B2 (en) | 2008-05-22 | 2012-12-25 | The Curators Of The University Of Missouri | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
US20130006073A1 (en) | 2008-05-22 | 2013-01-03 | Zhi Xu | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
US20130006072A1 (en) | 2008-05-22 | 2013-01-03 | Zhi Xu | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
US20130006070A1 (en) | 2008-05-22 | 2013-01-03 | Zhi Xu | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
WO2010017238A1 (en) | 2008-08-04 | 2010-02-11 | Masimo Laboratories, Inc. | Noninvasive measurement of glucose and other analytes |
US20100026995A1 (en) | 2008-08-04 | 2010-02-04 | Masimo Laboratories, Inc. | Multi-stream sensor for noninvasive measurement of blood constituents |
US20100252721A1 (en) | 2009-04-01 | 2010-10-07 | The Curators Of The University Of Missouri | Optical spectroscopy device for non-invasive blood glucose detection and associated method of use |
WO2010114736A1 (en) | 2009-04-01 | 2010-10-07 | The Curators Of The University Of Missouri | Optical spectroscopy device for non-invasive blood glucose detection and associated method of use |
Non-Patent Citations (83)
Title |
---|
Attached please find the Office Action dated Jun. 30, 2017 for the Indian application No. 4886/KOLNP/2010. |
Brazilian Office Action dated Mar. 10, 2022, Application No. PI0818177-2. |
European First Examination Report dated Jun. 4, 2018. EP Application No. 10759220.6. |
European Search Report dated Aug. 21, 2019 for European Application No. 19178081.6. |
European Search Report from European Application No. 17159427.8. |
Examiner's Decision of Rejection for JP Application 2010-527994 dated Dec. 10, 2013. |
Extended European Search Report for EP Application 08830786.3 dated Apr. 22, 2013. |
Extended European Search Report for EP Application 08836010.2 dated Mar. 8, 2016. |
Extended European Search Report for EP Application 09751083.8 dated Jul. 26, 2013. |
First Examination Report dated Oct. 27, 2017 for the Indian Application No. 1186/KOLNP/2010. |
he Decision for Refusal dated Feb. 13, 2020, from European Patent Application No. EP 10 759 220.6. |
Indian Examination Report dated Apr. 13, 2018, Application No. 41144/KOLNP/2011. |
International Preliminary Report on Patentability (Chapter II) for PCT/US2008/011438 dated Jun. 18, 2010. |
International Preliminary Report on Patentability (Chapter II) for PCT/US2009/037805 dated Dec. 14, 2010. |
International Preliminary Report on Patentability (Chapter II) for PCT/US2009/040942 dated Dec. 13, 2010. |
International Search Report and Written Opinion for PCT/US2010/028255 dated May 19, 2010. |
International Search Report for PCT/US/2008/010670 dated Nov. 21, 2008. |
International Search Report for PCT/US/2008/011438 dated Dec. 9, 2008. |
Office Action dated for RU Application 2011144084 dated Apr. 17, 2015. |
Office Action for AU Application 2008299938 dated Sep. 13, 2013. |
Office Action for AU Application 2010232841 dated Aug. 13, 2013. |
Office Action for CA Application 2699626 dated Feb. 27, 2015. |
Office Action for CA Application 2700996 dated Aug. 7, 2015. |
Office Action for CA Application 2700996 dated Jul. 30, 2014. |
Office Action for CA Application 2789658 dated Mar. 30, 2016. |
Office Action for CN Application 200880114960.3 dated Feb. 17, 2015. |
Office Action for CN Application 200880114960.3 dated Jan. 29, 2013. |
Office Action for CN Application 200980126116.7 dated Feb. 16, 2013. |
Office Action for CN Application 200980126116.7 dated Jun. 4, 2012. |
Office Action for CN Application 200980126116.7 dated Oct. 17, 2013. |
Office Action for CN Application 201080022242.0 dated Jul. 4, 2013. |
Office Action for CN Application 201080022242.0 dated Mar. 12, 2014. |
Office Action for CN Application 201210419740.X dated Feb. 28, 2014. |
Office Action for CN Application 201210419849.3 dated Jan. 6, 2014. |
Office Action for CN Application 201210420830.0 dated Jan. 5, 2015. |
Office Action for CN Application 201210420843.8 dated Feb. 17, 2014. |
Office Action for CN Application 201310489245 dated Jan. 25, 2016. |
Office Action for CN Application 201310489245.0 dated Feb. 26, 2015. |
Office Action for EP Application 08830786.3 dated Jan. 10, 2014. |
Office Action for EP Application 09751083.8 dated Feb. 24, 2015. |
Office Action for EP Application 09751083.8 dated Mar. 28, 2014. |
Office Action for EP Application 9751083.8 dated Jan. 26, 2016. |
Office Action for JP Application 2010-524873 dated Dec. 25, 2012. |
Office Action for JP Application 2010-524873 dated Nov. 19, 2013. |
Office Action for JP Application 2010-527994 dated Dec. 25, 2012. |
Office Action for JP Application 2011-501936 dated Aug. 5, 2014. |
Office Action for JP Application 2011-501936 dated Jun. 25, 2013. |
Office Action for JP Application 2011-510533 dated Dec. 3, 2013. |
Office Action for JP Application 2012-503498 dated Mar. 31, 2015. |
Office Action for JP Application 2014-245584 dated Jan. 5, 2016, includes English Translation. |
Office Action for RU Application 2010114587 dated Jun. 22, 2012. |
Office Action for RU Application 2010114587 dated Mar. 25, 2014. |
Office Action for RU Application 2010117396 dated Jun. 18, 2012. |
Office Action for RU Application 2010152373 dated Mar. 26, 2013. |
Office Action for U.S. Appl. No. 12/209,807 dated May 17, 2010. |
Office Action for U.S. Appl. No. 12/209,807 dated Sep. 17, 2010. |
Office Action for U.S. Appl. No. 12/256,028 dated May 24, 2010. |
Office Action for U.S. Appl. No. 12/256,028 dated Sep. 15, 2010. |
Office Action for U.S. Appl. No. 12/407,999 dated Apr. 6, 2012. |
Office Action for U.S. Appl. No. 12/407,999 dated Jan. 5, 2016. |
Office Action for U.S. Appl. No. 12/407,999 dated Nov. 20, 2014. |
Office Action for U.S. Appl. No. 12/407,999 dated Nov. 21, 2012. |
Office Action for U.S. Appl. No. 12/407,999 dated Oct. 10, 2013. |
Office Action for U.S. Appl. No. 12/425,535 dated Mar. 22, 2012. |
Office Action for U.S. Appl. No. 12/425,535 dated May 16, 2012. |
Office Action for U.S. Appl. No. 12/729,886 dated Mar. 12, 2013. |
Office Action for U.S. Appl. No. 12/729,886 dated Oct. 2, 2012. |
Office Action for U.S. Appl. No. 13/610,140 dated May 13, 2016. |
Office Action for U.S. Appl. No. 13/610,342 dated Apr. 14, 2016. |
Office Action for U.S. Appl. No. 13/610,342 dated Jan. 21, 2015. |
Office Action for U.S. Appl. No. 13/610,387 dated Apr. 14, 2016. |
Office Action for U.S. Appl. No. 13/610,387 dated Jan. 22, 2015. |
Office Action for U.S. Appl. No. 13/610,423 dated Jan. 22, 2015. |
Office Action for U.S. Appl. No. 13/610,423 dated Mar. 24, 2016. |
Texas Instruments TSL260, TSL261, TSL262 IR Light-to-Voltage Optical Sensors 1993. |
The Hearing Notice dated Nov. 8, 2019 form Indian Patent application No. 1186/KOLNP/2010. |
The Office Action dated Dec. 21, 2018 for Brazilian Patent Application No. PI0816925-0. |
The Office Action dated Jul. 7, 2020 for the Brazilian application No. PI1010304-0. |
The Office Action dated May 21, 2019 for Brazilian Patent Application No. PI0909825-9. |
The Official Letter dated Mar. 19, 2021 for the European Patent Application No. 08836010.2. |
Unfavorable opinion dated Jul. 31, 2019 for Brazilian Application No. PI01816925-0. |
Wagner et al., "Invasiveness as a Barrier to Self-Monitoring of Blood Glucose in Diabetes", Diabetes Technology & Therapeutics, Aug. 1, 2005. |
Web Page Document entitled http://www.orense.com/Diabetes_Monitoring dated Aug. 9, 2007. |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11986291B2 (en) | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis | |
US8552359B2 (en) | Optical spectroscopy device for non-invasive blood glucose detection and associated method of use | |
US12036019B2 (en) | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |